Cover Page
Cover Page - USD ($) $ in Billions | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 31, 2023 | Jun. 30, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Transition Report | false | ||
Entity File Number | 1-12981 | ||
Entity Registrant Name | AMETEK, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 14-1682544 | ||
Entity Address, Address Line One | 1100 Cassatt Road | ||
Entity Address, City or Town | Berwyn | ||
Entity Address, State or Province | PA | ||
Entity Address, Postal Zip Code | 19312-1177 | ||
City Area Code | 610 | ||
Local Phone Number | 647-2121 | ||
Title of 12(b) Security | Common Stock, $0.01 Par Value | ||
Trading Symbol | AME | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 25.2 | ||
Entity Common Stock, Shares Outstanding | 230,093,810 | ||
Documents Incorporated by Reference | Documents Incorporated by ReferencePart III incorporates information by reference from the Proxy Statement for the Annual Meeting of Stockholders on May 4, 2023 | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0001037868 | ||
Current Fiscal Year End Date | --12-31 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2022 | |
Audit Information [Abstract] | |
Auditor Name | ERNST & YOUNG LLP |
Auditor Location | Philadelphia, Pennsylvania |
Auditor Firm ID | 42 |
Consolidated Statement of Incom
Consolidated Statement of Income - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Net sales | $ 6,150,530 | $ 5,546,514 | $ 4,540,029 |
Cost of sales | 4,005,261 | 3,633,900 | 2,996,515 |
Selling, general and administrative | 644,577 | 603,944 | 515,630 |
Total operating expenses | 4,649,838 | 4,237,844 | 3,512,145 |
Operating income | 1,500,692 | 1,308,670 | 1,027,884 |
Interest expense | (83,186) | (80,381) | (86,062) |
Other income (expense), net | 11,186 | (5,119) | 140,487 |
Total | 1,428,692 | 1,223,170 | 1,082,309 |
Provision for income taxes | 269,150 | 233,117 | 209,870 |
Net income | $ 1,159,542 | $ 990,053 | $ 872,439 |
Basic earnings per share (in USD per share) | $ 5.04 | $ 4.29 | $ 3.80 |
Diluted earnings per share (in USD per share) | $ 5.01 | $ 4.25 | $ 3.77 |
Weighted average common shares outstanding: | |||
Basic shares | 230,208 | 230,955 | 229,435 |
Diluted shares | 231,536 | 232,813 | 231,150 |
Consolidated Statement of Compr
Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 1,159,542 | $ 990,053 | $ 872,439 |
Foreign currency translation: | |||
Translation adjustments | (123,756) | (47,331) | 64,521 |
Change in long-term intercompany notes | (21,419) | (16,333) | 16,695 |
Net investment hedge instruments gain (loss), net of tax of $(17,070), $(12,631) and $14,787 in 2022, 2021 and 2020, respectively | 52,416 | 39,047 | (45,716) |
Defined benefit pension plans: | |||
Net actuarial (loss) gain, net of tax of $4,769, $(15,298) and $8,637 in 2022, 2021 and 2020, respectively | (18,238) | 46,049 | (18,733) |
Amortization of net actuarial loss, net of tax of ($2,111), ($4,103) and ($3,539) in 2022, 2021 and 2020, respectively | 6,420 | 12,249 | 11,940 |
Amortization of prior service costs, net of tax of $(25), ($114) and $7 in 2022, 2021 and 2020, respectively | 76 | 343 | (36) |
Other comprehensive (loss) income | (104,501) | 34,024 | 28,671 |
Total comprehensive income | $ 1,055,041 | $ 1,024,077 | $ 901,110 |
Consolidated Statement of Com_2
Consolidated Statement of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | |||
Tax benefit (expense) from investment hedge instruments | $ (17,070) | $ (12,631) | $ 14,787 |
Tax benefit (expense) from change in pension plans | 4,769 | (15,298) | 8,637 |
Tax related to amortization of net actuarial loss | (2,111) | (4,103) | (3,539) |
Tax related to amortization of prior service costs | $ (25) | $ (114) | $ 7 |
Consolidated Balance Sheet
Consolidated Balance Sheet - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 345,386 | $ 346,772 |
Receivables | 919,335 | 829,213 |
Inventories, net | 1,044,284 | 769,175 |
Other current assets | 219,053 | 183,605 |
Total current assets | 2,528,058 | 2,128,765 |
Property, plant and equipment, net | 635,641 | 617,138 |
Right of use assets, net | 170,295 | 169,924 |
Goodwill | 5,372,562 | 5,238,726 |
Other intangibles, net | 3,342,085 | 3,368,629 |
Investments and other assets | 382,479 | 375,005 |
Total assets | 12,431,120 | 11,898,187 |
Current liabilities: | ||
Short-term borrowings and current portion of long-term debt, net | 226,079 | 315,093 |
Accounts payable | 497,134 | 470,252 |
Customer advanced payments | 357,674 | 298,728 |
Income taxes payable | 48,171 | 35,904 |
Accrued liabilities and other | 435,144 | 443,337 |
Total current liabilities | 1,564,202 | 1,563,314 |
Long-term debt, net | 2,158,928 | 2,229,148 |
Deferred income taxes | 694,267 | 719,675 |
Other long-term liabilities | 537,211 | 514,166 |
Total liabilities | 4,954,608 | 5,026,303 |
Stockholders’ equity: | ||
Preferred stock,$0.01 par value; authorized 5,000,000 shares; none issued | 0 | 0 |
Common stock, $0.01 par value; authorized 800,000,000 shares; issued: 2022 – 268,588,293 shares; 2021 – 267,800,160 shares | 2,700 | 2,689 |
Capital in excess of par value | 1,094,236 | 1,012,526 |
Retained earnings | 8,857,485 | 7,900,113 |
Accumulated other comprehensive loss | (574,945) | (470,444) |
Treasury stock: 2022 – 38,537,635 shares; 2021 – 36,137,864 shares | (1,902,964) | (1,573,000) |
Total stockholders’ equity | 7,476,512 | 6,871,884 |
Total liabilities and stockholders’ equity | $ 12,431,120 | $ 11,898,187 |
Consolidated Balance Sheet (Par
Consolidated Balance Sheet (Parenthetical) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 800,000,000 | 800,000,000 |
Common stock, shares issued | 268,588,293 | 267,800,160 |
Treasury stock, shares | 38,537,635 | 36,137,864 |
Consolidated Statement of Stock
Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands | Total | Capital stock | Capital in excess of par value | Retained earnings | Retained earnings Cumulative Effect, Period of Adoption, Adjustment | Foreign currency translation: | Defined benefit pension plans: | Accumulated other comprehensive loss income | Treasury stock |
Accounting standards update | Accounting Standards Update 2016-13 [Member] | ||||||||
Balance at the beginning of the year at Dec. 31, 2019 | $ 2,662 | $ 832,821 | $ 6,387,612 | $ (286,248) | $ (246,891) | $ (1,574,464) | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Shares issued | 14 | ||||||||
Issuance of common stock under employee stock plans | 47,366 | 13,879 | |||||||
Share-based compensation costs | 41,565 | ||||||||
Net income | $ 872,439 | 872,439 | |||||||
Cash dividends paid | (165,035) | ||||||||
Other | 0 | ||||||||
Translation adjustments | 64,521 | 64,521 | |||||||
Change in long-term intercompany notes | 16,695 | ||||||||
Net investment hedge instruments gain (loss), net of tax of $(17,070), $(12,631) and $14,787 in 2022, 2021 and 2020, respectively | (45,716) | ||||||||
Net actuarial (loss) gain, net of tax of $4,769, $(15,298) and $8,637 in 2022, 2021 and 2020, respectively | (18,733) | (18,733) | |||||||
Amortization of net actuarial loss, net of tax of ($2,111), ($4,103) and ($3,539) in 2022, 2021 and 2020, respectively | 11,940 | 11,940 | |||||||
Amortization of prior service costs, net of tax of $(25), ($114) and $7 in 2022, 2021 and 2020, respectively | (36) | (36) | |||||||
Purchase of treasury stock | (4,685) | ||||||||
Balance at the end of the year at Dec. 31, 2020 | $ 5,949,346 | 2,676 | 921,752 | 7,094,656 | $ (360) | (250,748) | (253,720) | $ (504,468) | (1,565,270) |
Accounting standards update | Accounting Standards Update 2016-13 [Member] | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Shares issued | 13 | ||||||||
Issuance of common stock under employee stock plans | 44,671 | 6,981 | |||||||
Share-based compensation costs | 46,103 | ||||||||
Net income | $ 990,053 | 990,053 | |||||||
Cash dividends paid | (184,595) | ||||||||
Other | (1) | ||||||||
Translation adjustments | (47,331) | (47,331) | |||||||
Change in long-term intercompany notes | (16,333) | ||||||||
Net investment hedge instruments gain (loss), net of tax of $(17,070), $(12,631) and $14,787 in 2022, 2021 and 2020, respectively | 39,047 | ||||||||
Net actuarial (loss) gain, net of tax of $4,769, $(15,298) and $8,637 in 2022, 2021 and 2020, respectively | 46,049 | 46,049 | |||||||
Amortization of net actuarial loss, net of tax of ($2,111), ($4,103) and ($3,539) in 2022, 2021 and 2020, respectively | 12,249 | 12,249 | |||||||
Amortization of prior service costs, net of tax of $(25), ($114) and $7 in 2022, 2021 and 2020, respectively | 343 | 343 | |||||||
Purchase of treasury stock | (14,700) | (14,711) | |||||||
Balance at the end of the year at Dec. 31, 2021 | $ 6,871,884 | 2,689 | 1,012,526 | 7,900,113 | 0 | (275,365) | (195,079) | (470,444) | (1,573,000) |
Accounting standards update | Accounting Standards Update 2016-13 [Member] | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Shares issued | 11 | ||||||||
Issuance of common stock under employee stock plans | 34,335 | 2,857 | |||||||
Share-based compensation costs | 47,375 | ||||||||
Net income | $ 1,159,542 | 1,159,542 | |||||||
Cash dividends paid | (202,169) | ||||||||
Other | (1) | ||||||||
Translation adjustments | (123,756) | (123,756) | |||||||
Change in long-term intercompany notes | (21,419) | ||||||||
Net investment hedge instruments gain (loss), net of tax of $(17,070), $(12,631) and $14,787 in 2022, 2021 and 2020, respectively | 52,416 | ||||||||
Net actuarial (loss) gain, net of tax of $4,769, $(15,298) and $8,637 in 2022, 2021 and 2020, respectively | (18,238) | (18,238) | |||||||
Amortization of net actuarial loss, net of tax of ($2,111), ($4,103) and ($3,539) in 2022, 2021 and 2020, respectively | 6,420 | 6,420 | |||||||
Amortization of prior service costs, net of tax of $(25), ($114) and $7 in 2022, 2021 and 2020, respectively | 76 | 76 | |||||||
Purchase of treasury stock | (332,800) | (332,821) | |||||||
Balance at the end of the year at Dec. 31, 2022 | $ 7,476,512 | $ 2,700 | $ 1,094,236 | $ 8,857,485 | $ 0 | $ (368,124) | $ (206,821) | $ (574,945) | $ (1,902,964) |
Consolidated Statement of Sto_2
Consolidated Statement of Stockholders' Equity (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Stockholders' Equity [Abstract] | |||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 |
Tax benefit (expense) from investment hedge instruments | $ (17,070) | $ (12,631) | $ 14,787 |
Tax benefit (expense) from change in pension plans | 4,769 | (15,298) | 8,637 |
Tax related to amortization of net actuarial loss | (2,111) | (4,103) | (3,539) |
Tax related to amortization of prior service costs | $ (25) | $ (114) | $ 7 |
Consolidated Statement of Cash
Consolidated Statement of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Operating activities: | |||
Net income | $ 1,159,542 | $ 990,053 | $ 872,439 |
Adjustments to reconcile net income to total operating activities: | |||
Depreciation and amortization | 319,427 | 292,112 | 255,275 |
Deferred income taxes | (67,818) | (29,762) | 1,839 |
Share-based compensation expense | 47,375 | 46,103 | 41,565 |
Gain on sale of business/investment | (3,584) | (6,349) | (141,020) |
Gain on sale of facilities | (7,054) | 0 | (7,523) |
Changes in assets and liabilities, net of acquisitions: | |||
(Increase) decrease in receivables | (86,713) | (172,791) | 163,471 |
(Increase) decrease in inventories and other current assets | (322,467) | (129,593) | 77,448 |
Increase in payables, accruals and income taxes | 95,481 | 212,101 | 7,017 |
Increase (decrease) in other long-term liabilities | 47,226 | (35,104) | 20,430 |
Pension contributions | (8,959) | (10,277) | (9,527) |
Other, net | (23,083) | 3,964 | (434) |
Total operating activities | 1,149,373 | 1,160,457 | 1,280,980 |
Investing activities: | |||
Additions to property, plant and equipment | (139,005) | (110,671) | (74,199) |
Purchases of businesses, net of cash acquired | (429,714) | (1,959,218) | (116,509) |
Proceeds from sale of business/investment | 3,734 | 12,000 | 245,311 |
Proceeds from sale of facilities | 11,754 | 2,341 | 9,508 |
Other, net | 471 | (294) | (2,481) |
Total investing activities | (552,760) | (2,055,842) | 61,630 |
Financing activities: | |||
Net change in short-term borrowings | (73,691) | 243,615 | (328,003) |
Repayments of long-term borrowings | 0 | (59,718) | (102,947) |
Repurchases of common stock | (332,821) | (14,711) | (4,685) |
Cash dividends paid | (202,169) | (184,595) | (165,035) |
Proceeds from stock option exercises | 49,937 | 60,297 | 64,903 |
Other, net | (16,955) | (5,551) | (3,669) |
Total financing activities | (575,699) | 39,337 | (539,436) |
Effect of exchange rate changes on cash and cash equivalents | (22,300) | (10,002) | 16,618 |
(Decrease) increase in cash and cash equivalents | (1,386) | (866,050) | 819,792 |
Cash and cash equivalents: | |||
Beginning of year | 346,772 | 1,212,822 | 393,030 |
End of year | $ 345,386 | $ 346,772 | $ 1,212,822 |
Significant Accounting Policies
Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies Basis of Consolidation The accompanying consolidated financial statements reflect the results of operations, financial position and cash flows of AMETEK, Inc. (the “Company”), and include the accounts of the Company and subsidiaries, after elimination of all intercompany transactions in the consolidation. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates and assumptions. Cash Equivalents, Securities and Other Investments All highly liquid investments with maturities of three months or less when purchased are considered cash equivalents. Accounts Receivable The Company maintains allowances for estimated credit losses resulting from the inability of customers to meet their financial obligations to the Company. The Company recognizes an allowance for credit losses, on all accounts receivable and contract assets, which considers risk of future credit losses based on factors such as historical experience, contract terms, as well as general and market business conditions, country, and political risk. Balances are written off when considered uncollectible. Bad debt expense was $3.7 million in 2022, $1.2 million in 2021 and $3.6 million in 2020. At December 31, 2022 and 2021, the allowance for estimated credit losses was $14.1 million and $11.2 million, respectively. Inventories The Company uses the first-in, first-out (“FIFO”) method of accounting, which approximates current replacement cost, for approximately 90% of its inventories at December 31, 2022. The last-in, first-out (“LIFO”) method of accounting is used to determine cost for the remaining 10% of the Company’s inventory at December 31, 2022. For inventories where cost is determined by the LIFO method, the FIFO value would have been $40.3 million and $29.8 million higher than the LIFO value reported in the consolidated balance sheet at December 31, 2022 and 2021, respectively. The Company provides estimated inventory reserves for slow-moving and obsolete inventory based on current assessments about future demand, market conditions, customers who may be experiencing financial difficulties and related management initiatives. Business Combinations The Company allocates the purchase price of an acquired company, including when applicable, the acquisition date fair value of contingent consideration between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values, with the residual of the purchase price recorded as goodwill. The results of operations of the acquired business are included in the Company’s operating results from the date of acquisition. Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for additions to plant facilities, or that extend their useful lives, are capitalized. The cost of minor tools, jigs and dies, and maintenance and repairs is charged to expense as incurred. Depreciation of plant and equipment is calculated principally on a straight-line basis over the estimated useful lives of the related assets. The range of lives for depreciable assets is generally three five Depreciation expense was $113.7 million, $108.5 million and $101.3 million for the years ended December 31, 2022, 2021 and 2020, respectively. Goodwill and Other Intangible Assets Goodwill and other intangible assets with indefinite lives, primarily trademarks and trade names, are not amortized; rather, they are tested for impairment at least annually. The Company identifies its reporting units at the component level, which is one level below its operating segments. Generally, goodwill arises from acquisitions of specific operating companies and is assigned to the reporting unit in which the operating company resides. The Company’s reporting units are divisions that are one level below its operating segments and for which discrete financial information is prepared and regularly reviewed by segment management. When testing goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the estimated fair value of a reporting unit is less than its carrying amount. If the Company performs a qualitative assessment and determines that an impairment is more likely than not, then performance of a quantitative impairment test is required. In conducting a qualitative assessment, the Company analyzes actual and forecasted net sales and selling profit for each reporting unit, as well as historical performance and the results of prior quantitative tests performed. Additionally, the Company assesses critical areas that may impact its business, including macroeconomic conditions, industry and market conditions, cost factors, or any relevant events and factors that may impact projected financial results. If performed, the quantitative goodwill impairment test is performed using a discounted cash flow analysis to determine the fair value of each reporting unit, which considers cash flows discounted at an appropriate discount rate. The annual goodwill impairment test requires the Company to make a number of assumptions and estimates concerning future levels of revenue growth, operating margins, depreciation, amortization and working capital requirements, which are based on the Company’s long-range plan and are considered level 3 inputs. The discount rate is an estimate of the overall after-tax rate of return required by a market participant whose weighted average cost of capital includes both equity and debt, including a risk premium. While the Company uses the best available information to prepare its cash flow and discount rate assumptions, actual future cash flows or market conditions could differ significantly resulting in future impairment charges related to recorded goodwill balances. During the fourth quarter of 2022, the Company completed its annual goodwill impairment tests and elected to perform a qualitative assessment. The impairment test for indefinite-lived intangibles other than goodwill (primarily trademarks and trade names) consists of a comparison of the estimated fair value of the indefinite-lived intangible asset to the carrying value of the asset as of the impairment testing date. The Company estimates the fair value of its indefinite-lived intangibles using the relief from royalty method using level 3 inputs for revenue growth rates and royalty rates. The fair value derived from the relief from royalty method is measured as the discounted cash flow savings realized from owning such trademarks and trade names and not having to pay a royalty for their use. The Company completed its required annual impairment tests in the fourth quarter of 2022, 2021, and 2020 and determined that the carrying values of the Company's goodwill were not impaired. The Company completed its required annual indefinite-lived intangibles impairment test as of October 1, 2022 and determined that the carrying values of certain of the Company's trademarks and trade names with indefinite lives were impaired as a result of higher discount rates driven by higher interest rates. As a result, during the fourth quarter of 2022, the Company recorded an immaterial non-cash impairment charge related to certain of the Company's trade names. The Company completed its required annual impairment tests in the fourth quarter of 2021 and 2020 and determined that the carrying values of the Company's other intangible assets with indefinite lives were not impaired. Other intangible assets with finite lives are evaluated for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of other intangible assets with finite lives is considered impaired when the total projected undiscounted cash flows from the asset group are less than the carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of those assets. Fair value is determined primarily using present value techniques based on projected cash flows from the asset group. Intangible assets, other than goodwill, with definite lives are amortized over their estimated useful lives. Patents and technology are being amortized over useful lives of nine ten Financial Instruments and Foreign Currency Translation Assets and liabilities of foreign operations are translated using exchange rates in effect at the balance sheet date and their results of operations are translated using average exchange rates for the year. Certain transactions of the Company and its subsidiaries are denominated in currencies other than their functional currency. Exchange gains and losses from those transactions are included in operating results for the year. The Company makes infrequent use of derivative financial instruments. Forward contracts are primarily entered into from time to time to hedge debt or foreign currency transactions, thereby minimizing the Company’s exposure to foreign currency fluctuation. In instances where transactions are designated as hedges of an underlying item, the gains and losses on those transactions are included in accumulated other comprehensive income within stockholders’ equity to the extent they are effective as hedges. An evaluation of hedge effectiveness is performed by the Company at inception and on an ongoing basis and any changes in the hedge are made as appropriate. Leases The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. The Company has lease agreements which include lease and non-lease components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable. Operating leases are included in right-of-use ("ROU") assets, accrued liabilities and other, and other long-term liabilities on our consolidated balance sheets. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company has no finance leases. The Company primarily leases buildings (real estate) and automobiles which are classified as operating leases. The lease term for all of the Company’s leases includes the non-cancellable period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company’s leases as the reasonably certain threshold is not met. Lease payments included in the measurement of the lease liability are comprised of fixed and variable payments that depend on an index or rate. Variable lease payments not dependent on a rate or index associated with the Company’s leases are recognized when the events, activities, or circumstances in the lease agreement on which those payments are assessed are probable. Variable lease payments are presented as operating expense in the Company’s income statement in the same line item as expense arising from fixed lease payments. Cash used in operations for operating leases is not materially different than total lease costs. Revenue Recognition Revenue is derived from sales of products and services. The Company’s products and services are marketed and sold worldwide through two operating groups: EIG and EMG. See Note 15 Descriptive Information about Reportable Segments. The majority of the Company’s revenues on product sales were recognized at a point in time when the customer obtains control of the product. The transfer in control of the product to the customer was typically evidenced by one or more of the following: the customer having legal title to the product, the Company’s present right to payment, the customer’s physical possession of the product, the customer accepting the product, or the customer having the benefits of ownership or risk of loss. For a small percentage of sales where title and risk of loss transfers at the point of delivery, the Company recognized revenue upon delivery to the customer, which is the point that control transferred, assuming all other criteria for revenue recognition were met. The Company determined that revenues from certain of its customer contracts met the criteria of satisfying its performance obligations over time, primarily in the areas of the manufacture of custom-made equipment and for service repairs of customer-owned equipment. Recognizing revenue over time for custom-manufactured equipment is based on the Company’s judgment that, in certain contracts, the product does not have an alternative use and the Company has an enforceable right to payment for performance completed to date. The Company recognizes incremental cost of obtaining contracts as an expense when incurred if the amortization period of the contract cost assets that the Company would have otherwise recognized is one year or less. These costs are included in Selling, general and administrative expenses in the consolidated statement of income. The determination of the revenue to be recognized in each period for performance obligations satisfied over time is based on the input method. The Company recognizes revenue over time as it performs on these contracts because the transfer of control to the customer occurs over time. Revenue is recognized based on the extent of progress towards completion of the performance obligation. The Company generally uses the total cost-to-cost input method of progress because it best depicts the transfer of control to the customer that occurs as costs are incurred. Under the cost-to-cost method, the extent of progress towards completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. On certain contracts, labor hours are used as the measure of progress when it is determined to be a better depiction of the transfer of control to the customer due to the timing and pattern of labor hours incurred. Performance obligations also include post-delivery service, installation and training. Post-delivery service revenues are recognized over the contract term. Installation and training revenues are recognized over the period the service is provided. Warranty terms in customer contracts can also be considered separate performance obligations if the warranty provides services beyond assurance that a product complies with agreed-upon specification or if a warranty can be purchased separately. The Company does not incur significant obligations for customer returns and refunds. The Company has certain contracts with variable consideration in the form of volume discounts, rebates and early payment options, which may affect the transaction price used as the basis for revenue recognition. In these contracts, the amount of the variable consideration is allocated among the various performance obligations in the customer contract based on the relative standalone selling price of each performance obligation to the total standalone value of all the performance obligations. Payment terms generally begin upon shipment of the product. The Company does have contracts with multiple billing terms that are all due within one year from when the product is delivered. No significant financing component exists. Payment terms are generally 30-60 days from the time of shipment or customer acceptance, but terms can be shorter or longer, not exceeding one year. For customer contracts that have revenue recognized over time, revenue is generally recognized prior to a payment being due from the customer. In such cases, the Company recognizes a contract asset at the time the revenue is recognized. When payment becomes due based on the contract terms, the Company reduces the contract asset and records a receivable. In contracts with billing milestones or in other instances with a long production cycle or concerns about credit, customer advance payments are received. The Company may receive a payment in excess of revenue recognized to that date. In these circumstances, a contract liability is recorded. Contract liabilities are derecognized when the performance obligations are satisfied, and revenue is recognized. Research and Development Research and development costs are included in Cost of sales as incurred and were $198.8 million in 2022, $194.2 million in 2021 and $158.9 million in 2020. Shipping and Handling Costs Shipping and handling costs are included in Cost of sales and were $103.7 million in 2022, $86.1 million in 2021 and $56.8 million in 2020. Share-Based Compensation The Company expenses the fair value of share-based awards made under its share-based plans in the consolidated financial statements over their requisite service period of the grants. Income Taxes The Company conducts a broad range of operations around the world and is therefore subject to complex tax regulations in numerous international taxing jurisdictions, resulting at times in tax audits, disputes and potential litigation, the outcome of which is uncertain. Management must make judgments currently about such uncertainties and determine estimates of the Company’s tax assets and liabilities. To the extent the final outcome differs, future adjustments to the Company’s tax assets and liabilities may be necessary. The Company assesses the realizability of its deferred tax assets, taking into consideration the Company’s forecast of future taxable income, available net operating loss carryforwards and available tax planning strategies that could be implemented to realize the deferred tax assets. Based on this assessment, management must evaluate the need for, and amount of, valuation allowances against the Company’s deferred tax assets. To the extent facts and circumstances change in the future, adjustments to the valuation allowances may be required. The Company assesses the uncertainty in its tax positions, by applying a minimum recognition threshold which a tax position is required to meet before a tax benefit is recognized in the financial statements. Once the minimum threshold is met, using a more likely than not standard, a series of probability estimates is made for each item to properly measure and record a tax benefit. The tax benefit recorded is generally equal to the highest probable outcome that is more than 50% likely to be realized after full disclosure and resolution of a tax examination. The underlying probabilities are determined based on the best available objective evidence such as recent tax audit outcomes, published guidance, external expert opinion, or by analogy to the outcome of similar issues in the past. There can be no assurance that these estimates will ultimately be realized given continuous changes in tax policy, legislation and audit practice. The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense. Pensions The Company has U.S. and foreign defined benefit and defined contribution pension plans. The key assumptions in determining the Company’s pension income or expense are the assumed pension liability discount rate and the expected return on plan assets. All unrecognized prior service costs, remaining transition obligations or assets and actuarial gains and losses have been recognized, net of tax effects, as a charge to accumulated other comprehensive income in stockholders’ equity and will be amortized as a component of net periodic pension cost. The Company uses a measurement date of December 31 (its fiscal year end) for its U.S. and foreign defined benefit plans. Earnings Per Share The calculation of basic earnings per share is based on the weighted average number of common shares considered outstanding during the periods. The calculation of diluted earnings per share reflects the effect of all potentially dilutive securities (principally outstanding stock options and restricted stock grants). The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows for the years ended December 31: 2022 2021 2020 (In thousands) Weighted average shares: Basic shares 230,208 230,955 229,435 Equity-based compensation plans 1,328 1,858 1,715 Diluted shares 231,536 232,813 231,150 The calculation of diluted earnings per share for 2022 excluded an immaterial number of stock options because the exercise prices of these stock options exceeded the average market price of the Company’s common shares, and the effect of their inclusion would have been antidilutive. There were no antidilutive shares in 2021 and 2020. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Recently Adopted Accounting Pronouncement In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 8050): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), which provides a single comprehensive accounting model for the acquisition of contract balances under ASC 805. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company early adopted the ASU on January 1, 2022, and the amendments in this ASU were applied on a prospective basis to all periods presented. The adoption of ASU 2021-08 did not impact the Company’s consolidated results of operations, financial position, cash flows or financial statement disclosures. |
Revenues
Revenues | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenues | Revenues The outstanding contract asset and liability accounts were as follows: 2022 2021 (In thousands) Contract assets – January 1 $ 95,274 $ 68,971 Contract assets – December 31 119,741 95,274 Change in contract assets – increase 24,467 26,303 Contract liabilities – January 1 328,816 215,093 Contract liabilities – December 31 398,692 328,816 Change in contract liabilities – (increase) (69,876) (113,723) Net change $ (45,409) $ (87,420) The net change in 2022 and 2021 was primarily driven by the receipt of advance payments from customers significantly exceeding the recognition of revenue and customer advance payments from acquired businesses. For the years ended December 31, 2022 and 2021, the Company recognized revenue of $272 million and $184 million, respectively, that was previously included in the beginning balance of contract liabilities. Contract assets are reported as a component of Other current assets in the consolidated balance sheet. At December 31, 2022 and 2021, $41.0 million and $30.1 million, respectively, of Customer advanced payments (contract liabilities) were recorded in Other long-term liabilities in the consolidated balance sheet. The remaining performance obligations exceeding one year as of December 31, 2022 and 2021 were $526.0 million and $342.5 million, respectively. Remaining performance obligations represent the transaction price of firm, non-cancelable orders, with expected delivery dates to customers greater than one year from the balance sheet date, for which the performance obligation is unsatisfied or partially unsatisfied. These performance obligations will be substantially satisfied within two Geographic Areas Net sales were attributed to geographic areas based on the location of the customer. Information about the Company’s operations in different geographic areas was as follows for the year ended December 31: 2022 EIG EMG Total (In thousands) United States $ 2,171,684 $ 982,579 $ 3,154,263 International (1) : United Kingdom 92,668 117,788 210,456 European Union countries 510,052 420,756 930,808 Asia 1,050,843 266,011 1,316,854 Other foreign countries 404,106 134,043 538,149 Total international 2,057,669 938,598 2,996,267 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 _________________ (1) Includes U.S. export sales of $1,688.7 million. 2021 EIG EMG Total (In thousands) United States $ 1,910,203 $ 890,737 $ 2,800,940 International (1) : United Kingdom 96,206 121,290 217,496 European Union countries 482,426 403,890 886,316 Asia 927,027 254,370 1,181,397 Other foreign countries 347,896 112,469 460,365 Total international 1,853,555 892,019 2,745,574 Consolidated net sales $ 3,763,758 $ 1,782,756 $ 5,546,514 _________________ (1) Includes U.S. export sales of $1,475.6 million. 2020 EIG EMG Total (In thousands) United States $ 1,513,967 $ 816,159 $ 2,330,126 International (1) : United Kingdom 54,158 117,469 171,627 European Union countries 371,884 324,203 696,087 Asia 769,532 189,987 959,519 Other foreign countries 280,387 102,283 382,670 Total international 1,475,961 733,942 2,209,903 Consolidated net sales $ 2,989,928 $ 1,550,101 $ 4,540,029 _________________ (1) Includes U.S. export sales of $1,196.4 million Major Products and Services The Company’s major products and services in the reportable segments were as follows for the year ended December 31: 2022 EIG EMG Total (In thousands) Process and analytical instrumentation $ 3,061,263 $ — $ 3,061,263 Aerospace and power 1,168,090 549,735 1,717,825 Automation and engineered solutions — 1,371,442 1,371,442 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 2021 EIG EMG Total (In thousands) Process and analytical instrumentation $ 2,627,476 $ — $ 2,627,476 Aerospace and power 1,136,282 506,925 1,643,207 Automation and engineered solutions — 1,275,831 1,275,831 Consolidated net sales $ 3,763,758 $ 1,782,756 $ 5,546,514 2020 EIG EMG Total (In thousands) Process and analytical instrumentation $ 2,199,167 $ — $ 2,199,167 Aerospace and power 790,761 466,343 1,257,104 Automation and engineered solutions — 1,083,758 1,083,758 Consolidated net sales $ 2,989,928 $ 1,550,101 $ 4,540,029 Timing of Revenue Recognition The Company’s timing of revenue recognition was as follows for the year ended December 31: 2022 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,471,118 $ 1,680,558 $ 5,151,676 Products and services transferred over time 758,235 240,619 998,854 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 2021 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,048,819 $ 1,596,911 $ 4,645,730 Products and services transferred over time 714,939 185,845 900,784 Consolidated net sales $ 3,763,758 $ 1,782,756 $ 5,546,514 2020 EIG EMG Total (In thousands) Products transferred at a point in time $ 2,427,254 $ 1,390,574 $ 3,817,828 Products and services transferred over time 562,674 159,527 722,201 Consolidated net sales $ 2,989,928 $ 1,550,101 $ 4,540,029 Product Warranties The Company provides limited warranties in connection with the sale of its products. The warranty periods for products sold vary among the Company’s operations, but the majority do not exceed one year. The Company calculates its warranty expense provision based on its historical warranty experience and adjustments are made periodically to reflect actual warranty expenses. Product warranty obligations are reported as a component of Accrued liabilities and other in the consolidated balance sheet. Changes in the accrued product warranty obligation were as follows: 2022 2021 2020 (In thousands) Balance at the beginning of the year $ 27,478 $ 27,839 $ 27,611 Accruals for warranties issued during the year 11,414 11,518 12,000 Settlements made during the year (11,835) (13,669) (14,602) Warranty accruals related to acquired businesses and other during the year (570) 1,790 2,830 Balance at the end of the year $ 26,487 $ 27,478 $ 27,839 |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company utilizes a hierarchy for disclosure of the inputs to the valuations used to measure fair value. The hierarchy prioritizes the inputs into three broad levels as follows: Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities Level 2 - quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument Level 3 - unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The following tables provide the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31: 2022 Total Level 1 Level 2 Level 3 (In thousands) Mutual fund investments $ 9,856 $ 9,856 $ — $ — Foreign currency forward contracts 3,032 — 3,032 — 2021 Total Level 1 Level 2 Level 3 (In thousands) Mutual fund investments $ 10,703 $ 10,703 $ — $ — The fair value of mutual fund investments is based on quoted market prices. The mutual fund investments are shown as a component of long-term assets in the consolidated balance sheet. For the years ended December 31, 2022 and 2021, gains and losses on the investments were not significant. Foreign Currency At December 31, 2022 the Company had a Euro forward contract for a total notional value of 40.0 million Euros and a Canadian dollar forward contract for a notional value of 26.5 million dollars. At December 31, 2021 the Company had no foreign currency forward contracts outstanding. Foreign currency forward contracts are valued as level 2 assets as they are corroborated by foreign currency exchange rates and shown as a component of other current assets in the consolidated balance sheet. For the year ended December 31, 2022 and 2021, realized gains and losses on foreign currency forward contracts were not significant. The Company does not typically designate its foreign currency forward contracts as accounting hedges. Financial Instruments Cash, cash equivalents and mutual fund investments are recorded at fair value at December 31, 2022 and 2021 in the consolidated balance sheet. The fair value of short-term borrowings, net approximates the carrying value. The Company’s long-term debt, net is all privately held with no public market for this debt, therefore, the fair value of long-term debt, net was computed based on comparable current market data for similar debt instruments and is considered to be a level 3 liability. At December 31, 2022 and 2021, the fair value of long-term debt (including current portion) was $2,010.9 million and $2,378.9 million and the recorded amount of long-term debt (including current portion) was $2,161.6 million and $2,233.7 million, respectively. See Note 10 for long-term debt principal amounts, interest rates and maturities. |
Hedging Activities
Hedging Activities | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Hedging Activities | Hedging Activities The Company has designated certain foreign-currency-denominated long-term borrowings as hedges of the net investment in certain foreign operations. As of December 31, 2022, and 2021, these net investment hedges included British-pound and Euro-denominated long-term debt. These borrowings were designed to create net investment hedges in each of the designated foreign subsidiaries. The Company designated the British-pound- and Euro-denominated loans referred to above as hedging instruments to offset translation gains or losses on the net investment due to changes in the British pound and Euro exchange rates. These net investment hedges are evidenced by management’s contemporaneous documentation supporting the hedge designation. Any gain or loss on the hedging instruments (the debt) following hedge designation is reported in accumulated other comprehensive income in the same manner as the translation adjustment on the hedged investment based on changes in the spot rate, which is used to measure hedge effectiveness. At December 31, 2022 and 2021, the Company had $271.7 million and $304.6 million, respectively, of British-pound denominated loans, which were designated as a hedge against the net investment in British pound functional currency foreign subsidiaries. At December 31, 2022 and 2021, the Company had $572.1 million and $654.1 million, respectively, in Euro-denominated loans, which were designated as a hedge against the net investment in Euro functional currency foreign subsidiaries. As a result of the British-pound and Euro-denominated loans being designated and 100% effective as net investment hedges, $69.5 million of pre-tax currency remeasurement losses and $51.7 million of pre-tax currency remeasurement losses have been included in the foreign currency translation component of other comprehensive income for the years ended December 31, 2022 and 2021, respectively. |
Acquisitions and Divestiture
Acquisitions and Divestiture | 12 Months Ended |
Dec. 31, 2022 | |
Business Combinations [Abstract] | |
Acquisitions and Divestiture | Acquisitions and Divestiture Acquisitions The Company spent $429.7 million in cash, net of cash acquired, to acquire Navitar, Inc.("Navitar") in September 2022 and RTDS Technologies Inc. ("RTDS") in October 2022. Navitar is a market leader in the design, development and manufacturing of customized, fully integrated optical imaging systems, cameras, components and software. RTDS is a leading provider of real-time power simulation systems used by utilities, and research and education institutions in the development and testing of the electric power grid and renewable energy applications. Navitar and RTDS are part of EIG. The following table represents the allocation of the purchase price for the net assets of the 2022 acquisitions based on the estimated fair values at acquisition (in millions): Property, plant and equipment $ 11.8 Goodwill 197.8 Other intangible assets 213.3 Deferred income taxes (23.5) Net working capital and other (1) 30.3 Total cash paid $ 429.7 ______________________ (1) Includes $18.4 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal. The amount allocated to goodwill is reflective of the benefits the Company expects to realize from the Navitar and RTDS acquisitions. Navitar's market leading optical components and solutions complement the Company's existing optics portfolio. RTDS' products and solutions complement the Company's existing power instruments businesses. The Company expects approximately $71.4 million of the goodwill relating to the acquisitions will be tax deductible in future years. At December 31, 2022, the purchase price allocated to other intangible assets of $213.3 million consists of $37.2 million of indefinite-lived intangible trade names, which are not subject to amortization. The remaining $176.1 million of other intangible assets consists of $120.1 million of customer relationships, which are being amortized over a period of 19 years and $56.0 million of purchased technology, which is being amortized over a period of 11 to 15 years. Amortization expense for each of the next five years for the acquisitions is expected to be $11.1 million per year. The Company is in the process of finalizing the measurement of the intangible assets and tangible assets and liabilities, as well as accounting for income taxes, for Navitar and RTDS. The acquisitions had an immaterial impact on reported net sales, net income, and diluted earnings per share for the year ended December 31, 2022. Had the acquisitions been made at the beginning of 2022 or 2021, pro forma net sales, net income, and diluted earnings per share for the year ended December 31, 2022 and 2021, would not have been materially different than the amounts reported. In 2021, the Company spent $1,959.2 million in cash, net of cash acquired, to acquire Magnetrol International ("Magnetrol"), Crank Software, and EGS Automation ("EGS") in March 2021, NSI-MI Technologies ("NSI-MI") and Abaco Systems, Inc. ("Abaco") in April 2021, and Alphasense in November 2021. Magnetrol is a leading provider of level and flow control solutions for challenging process applications across a diverse set of end markets including medical, pharmaceutical, oil and gas, food and beverage, and general industrial. Crank Software is a leading provider of embedded graphical user interface software and services. EGS is an automation solutions provider that designs and manufactures highly engineered, customized robotic solutions used in critical applications for the medical, food and beverage, and general industrial markets. NSI-MI is a leading provider of radio frequency and microwave test and measurement systems for niche applications across the aerospace, defense, automotive, wireless communications, and research markets. Abaco specializes in open-architecture computing and electronic systems for aerospace, defense, and specialized industrial markets and is a leading provider of mission critical embedded computing systems. Alphasense is a leading provider of gas and particulate sensors for use in environmental, health and safety, and air quality applications. Magnetrol, Crank Software, NSI-MI, Abaco, and Alphasense are part of EIG. EGS is part of EMG. In 2020, the Company spent $116.5 million in cash, net of cash acquired, to acquire IntelliPower in January 2020. IntelliPower designs and manufactures a broad portfolio of ruggedized solutions including uninterruptible power systems, external battery packs, power distribution units and power conditioners. IntelliPower was privately held and is headquartered in Orange, California. IntelliPower is part of EIG. Divestiture The Company completed its sale of Reading Alloys to Kymera International in March 2020 for net cash proceeds of $245.3 million. The transaction resulted in a pre-tax gain of $141.0 million, recorded in Other Income (expense) in the Consolidated Statement of Income, and income tax expense of $31.4 million in connection with the sale. Reading Alloys revenue and costs were reported within the EMG segment through the date of sale. |
Goodwill and Other Intangible A
Goodwill and Other Intangible Assets | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Other Intangible Assets | Goodwill and Other Intangible Assets The changes in the carrying amounts of goodwill by segment were as follows: EIG EMG Total (In millions) Balance at December 31, 2020 $ 3,050.3 $ 1,174.6 $ 4,224.9 Goodwill acquired 1,037.9 5.9 1,043.8 Purchase price allocation adjustments and other 1.9 — 1.9 Foreign currency translation adjustments (16.3) (15.6) (31.9) Balance at December 31, 2021 4,073.8 1,164.9 5,238.7 Goodwill acquired 197.8 — 197.8 Purchase price allocation adjustments and other 1.8 — 1.8 Foreign currency translation adjustments (37.3) (28.4) (65.7) Balance at December 31, 2022 $ 4,236.1 $ 1,136.5 $ 5,372.6 Other intangible assets were as follows at December 31: 2022 2021 (In thousands) Definite-lived intangible assets (subject to amortization): Patents $ 46,418 $ 48,071 Purchased technology 722,277 677,896 Customer lists 3,023,762 2,930,120 3,792,457 3,656,087 Accumulated amortization: Patents (37,215) (37,713) Purchased technology (269,155) (235,989) Customer lists (1,033,658) (888,092) (1,340,028) (1,161,794) Net intangible assets subject to amortization 2,452,429 2,494,293 Indefinite-lived intangible assets (not subject to amortization): Trademarks and trade names 889,656 874,336 $ 3,342,085 $ 3,368,629 Amortization expense was $205.8 million, $183.6 million, and $154.0 for the years ended December 31, 2022, 2021 and 2020, respectively. Amortization expense for each of the next five years is expected to approximate $204 million per year, not considering the impact of potential future acquisitions. |
Other Consolidated Balance Shee
Other Consolidated Balance Sheet Information | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Other Consolidated Balance Sheet Information | Other Consolidated Balance Sheet Information December 31, 2022 2021 (In thousands) INVENTORIES, NET Finished goods and parts $ 130,989 $ 89,985 Work in process 138,043 122,356 Raw materials and purchased parts 775,252 556,834 $ 1,044,284 $ 769,175 PROPERTY, PLANT AND EQUIPMENT, NET Land $ 55,915 $ 41,709 Buildings 365,679 343,996 Machinery and equipment 1,199,600 1,149,316 1,621,194 1,535,021 Less: Accumulated depreciation (985,553) (917,883) $ 635,641 $ 617,138 ACCRUED LIABILITIES AND OTHER Employee compensation and benefits $ 213,478 $ 205,994 Product warranty obligation 26,487 27,478 Realignment 34,394 30,476 Short term lease liability 46,366 47,353 Other 114,419 132,036 $ 435,144 $ 443,337 |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The components of income before income taxes and the details of the provision for income taxes were as follows for the years ended December 31: 2022 2021 2020 (In thousands) Income before income taxes: Domestic $ 893,478 $ 958,206 $ 810,844 Foreign 535,214 264,964 271,465 Total $ 1,428,692 $ 1,223,170 $ 1,082,309 Provision for income taxes: Current: Federal $ 183,619 $ 99,706 $ 126,427 Foreign 119,148 146,890 61,672 State 34,201 16,282 19,932 Total current 336,968 262,878 208,031 Deferred: Federal (37,810) 23,538 (1,254) Foreign (20,818) (56,572) (4,072) State (9,190) 3,273 7,165 Total deferred (67,818) (29,761) 1,839 Total provision $ 269,150 $ 233,117 $ 209,870 Significant components of the deferred tax (asset) liability were as follows at December 31: 2022 2021 (In thousands) Non-current deferred tax (asset) liability: Differences in basis of property and accelerated depreciation (1) $ 43,594 $ 44,199 Reserves not currently deductible (131,958) (118,578) Pensions 66,558 63,329 Differences in basis of intangible assets and accelerated amortization 726,525 768,542 Net operating loss carryforwards (54,318) (44,164) Share-based compensation (13,279) (12,728) Foreign Tax Credit Carryforwards (2,317) (2,291) Unremitted earnings 12,429 11,361 Other (13,448) (28,343) 633,786 681,327 Less: Valuation allowance 9,613 11,349 643,399 692,676 Portion included in non-current assets 50,868 26,999 Gross non-current deferred tax liability $ 694,267 $ 719,675 ______________________ (1) Presented net of deferred tax assets of approximately $34.1 million and $33.3 million at December 31, 2022 and 2021, respectively, resulting from lease obligations. The Company’s effective tax rate reconciles to the U.S. Federal statutory rate as follows for the years ended December 31: 2022 2021 2020 U.S. Federal statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal income tax benefit 1.6 1.5 2.3 Foreign operations, net (1.0) (0.4) (1.4) U.S. Benefits for Manufacturing, Export and credits (2.9) (2.6) (1.9) Uncertain Tax Items 1.0 (0.1) (1.3) Stock compensation (0.9) (1.7) (1.0) U.S. Tax on Foreign Earnings 0.5 3.9 2.2 U.S. General Basket FTC (0.1) (2.9) (0.1) Other (0.4) 0.3 (0.5) Consolidated effective tax rate 18.8 % 19.1 % 19.4 % The Company elected to pay the cash tax cost of the one-time mandatory tax on previously deferred earnings of non-U.S. subsidiaries over an eight-year period. As of December 31, 2022, the Company has a remaining cash tax obligation of $35.9 million, all of which is classified as non-current. The Company has evaluated the impact of the global intangible low-taxed income (“GILTI”) section of the Tax Act and has made a tax accounting policy election to record the annual tax cost of GILTI as a current period expense when incurred and, as such, will not be measuring an impact of GILTI in its determination of deferred taxes. As a result of the one-time mandatory deemed repatriation and the taxable inclusions under the GILTI provisions of the Tax Act, the Company has approximately $898.0 million in previously taxed income (“PTI”) as of December 31, 2022 which can be repatriated without incremental U.S. Federal tax. The Company intends to reinvest its earnings indefinitely in operations outside the United States except to the extent of the PTI. There has been no provision for U.S. deferred income taxes for the undistributed earnings over PTI of approximately $60.4 million and $186.4 million at December 31, 2022 and 2021 respectively because determination of the amount of the unrecognized deferred income tax liability on these undistributed earnings is not practicable. As of December 31, 2022, and 2021, the Company recorded deferred income taxes totaling $12.4 million and $11.4 million respectively in state income and foreign withholding taxes expected to be incurred when the cash amounts related to the mandatory tax are ultimately repatriated to the U.S. The Company is acquisitive and at times acquires entities with tax attributes (net operating losses or tax credits) that carry over to post-acquisition tax periods of the Company. At December 31, 2022, the Company had tax effected benefits, net of uncertain tax positions of $54.3 million related to net operating loss carryforwards, which will be available to offset future income taxes payable, subject to certain annual or other limitations based on foreign and U.S. tax laws. This amount includes net operating loss carryforwards of $2.2 million for federal income tax purposes with no valuation allowance for the U.S. consolidated group, $10.7 million for state income tax purposes with a valuation allowance of $2.7 million, and $41.4 million for foreign income tax purposes with a valuation allowance of $2.7 million. These net operating loss carryforwards, if not used, will expire between 2023 and 2042. At December 31, 2022, the Company had tax effected benefits of $9.3 million related to tax credit carryforwards, which will be available to offset future income taxes payable, subject to certain annual or other limitations based on foreign and U.S. tax laws. This amount includes tax credit carryforwards of $2.9 million for federal income tax purposes with a valuation allowance of $0.6 million, $6.4 million for state income tax purposes with a valuation allowance of $2.4 million, and no remaining credit carryforwards for foreign income tax purposes. These tax credit carryforwards, if not used, will expire between 2023 and 2042. The Company maintains a valuation allowance (VA) to reduce certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to deferred tax assets established for federal and state credits and state net operating loss carryforwards. In 2022, the Company recorded a net decrease of $1.7 million in the valuation allowance. The reduction primarily relates to the reversal of a valuation allowance on federal tax credits in the amount of $2.3 million, which after considering significant positive evidence the company will be able to utilize in the future. Additionally, there was a reduction of $0.3 million to the valuation allowance due to changes in net operating losses in the normal course of business. Offsetting the reductions was an increase of $1.3 million relating to foreign net operating losses which are not expected to be utilized. At December 31, 2022, the Company had gross unrecognized tax benefits of $174.7 million, of which $128.5 million, if recognized, would impact the effective tax rate. At December 31, 2021, the Company had gross unrecognized tax benefits of $147.0 million, of which $110.0 million, if recognized, would impact the effective tax rate. At December 31, 2022 and 2021, the Company reported $12.4 million and $9.1 million, respectively, related to interest and penalties as a component of other long term liabilities in the consolidated balance sheet. During 2022, the Company recognized a net expense of $3.2 million, and in 2021 a net benefit of $2.5 million, for interest and penalties related to uncertain tax positions in the consolidated statement of income as a component of income tax expense. Approximately 64% of the Company’s overall tax liability is incurred in the United States. The Company files income tax returns in various other state and foreign tax jurisdictions, in some cases for multiple legal entities per jurisdiction. Generally, the Company has open tax years subject to tax audit on average of between three and six years in these jurisdictions. At December 31, 2022, the Internal Revenue Service ("IRS") audit of the Company's consolidated U.S. income tax returns for the year 2018 and 2019 is ongoing. The Company has not materially extended any other statutes of limitation for any significant location and has reviewed and accrued for, where necessary, tax liabilities for open periods including state and foreign jurisdictions that remain subject to examination. There have been no penalties asserted or imposed by the IRS related to substantial understatement of income, gross valuation misstatement or failure to disclose a listed or reportable transaction. During 2022, the Company added $43.4 million of tax, interest and penalties related to identified uncertain tax positions and reversed $4.4 million of tax and interest related to statute expirations and settlement of prior uncertain positions. During 2021, the Company added $58.6 million of tax, interest and penalties related to identified uncertain tax positions and reversed $35.2 million of tax and interest related to statute expirations and settlement of prior uncertain positions. The following is a reconciliation of the liability for uncertain tax positions at December 31: 2022 2021 2020 (In millions) Balance at the beginning of the year $ 147.0 $ 100.7 $ 109.1 Additions for tax positions related to the current year 29.3 41.4 15.6 Additions for tax positions of prior years 2.1 34.9 6.2 Reductions for tax positions of prior years (1.0) (1.5) (0.3) Reductions related to settlements with taxing authorities (0.2) (0.1) (0.5) Reductions due to statute expirations (2.5) (28.4) (29.4) Balance at the end of the year $ 174.7 $ 147.0 $ 100.7 In 2022, the additions above primarily reflect the increase in tax liabilities for uncertain tax positions related to certain higher transfer pricing risks for intangible assets. The reductions above primarily relate to statute expirations. The net increase of $27.7 million in uncertain tax positions resulted in an increase of $23.1 million to income tax expense and the remainder primarily in long term receivable. At December 31, 2022, tax, interest and |
Debt
Debt | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | Debt Long-term debt, net consisted of the following at December 31: 2022 2021 (In thousands) U.S. dollar 3.73% senior notes due September 2024 $ 300,000 $ 300,000 U.S. dollar 3.91% senior notes due June 2025 50,000 50,000 U.S. dollar 3.96% senior notes due August 2025 100,000 100,000 U.S. dollar 4.18% senior notes due December 2025 275,000 275,000 U.S. dollar 3.83% senior notes due September 2026 100,000 100,000 U.S. dollar 4.32% senior notes due December 2027 250,000 250,000 U.S. dollar 4.37% senior notes due December 2028 50,000 50,000 U.S. dollar 3.98% senior notes due September 2029 100,000 100,000 U.S. dollar 4.45% senior notes due August 2035 50,000 50,000 British pound 2.59% senior note due November 2028 181,157 203,046 British pound 2.70% senior note due November 2031 90,579 101,510 Euro 1.34% senior notes due October 2026 320,808 341,284 Euro 1.71% senior notes due December 2027 80,205 85,323 Euro 1.53% senior notes due October 2028 213,894 227,541 Revolving credit facility borrowings 219,000 314,480 Other, principally foreign 11,759 1,976 Less: Debt issuance costs (7,395) (5,919) Total debt, net 2,385,007 2,544,241 Less: Current portion, net (226,079) (315,093) Total long-term debt, net $ 2,158,928 $ 2,229,148 Maturities of long-term debt borrowings outstanding at December 31, 2022 were as follows: $300.0 million in 2024; $425.0 million in 2025; $420.8 million in 2026; $330.2 million in 2027; $445.1 million in 2027; and $240.6 million in 2028 and thereafter. In the fourth quarter of 2021, the Company paid in full, at maturity, a 55 million Swiss franc ($59.7 million) in aggregate principal amount of 2.44% senior note. In December 2018, the Company completed a private placement agreement to sell $575 million and 75 million Euros in senior notes to a group of institutional investors (the “2018 Private Placement”) utilizing two funding dates. The first funding occurred in December 2018 for $475 million and 75 million Euros ($80.2 million at December 31, 2022). The second funding was in January 2019 for $100 million. The 2018 Private Placement senior notes carry a weighted average interest rate of 3.93% and are subject to certain customary covenants, including financial covenants that, among other things, require the Company to maintain certain debt-to-EBITDA (earnings before interest, income taxes, depreciation and amortization) and interest coverage ratios. In September 2014, the Company issued $300 million in aggregate principal amount of 3.73% senior notes due September 2024, $100 million in aggregate principal amount of 3.83% senior notes due September 2026 and $100 million in aggregate principal amount of 3.98% senior notes due September 2029. In June 2015, the Company issued $50 million in aggregate principal amount of 3.91% senior notes due June 2025. In August 2015, the Company issued $100 million in aggregate principal amount of 3.96% senior notes due August 2025 and $50 million in aggregate principal amount of 4.45% senior notes due August 2035. In October 2016, the Company issued 300 million Euros ($320.8 million at December 31, 2022) in aggregate principal amount of 1.34% senior notes due October 2026 and 200 million Euros ($213.9 million at December 31, 2022) in aggregate principal amount of 1.53% senior notes due October 2028. In November 2016, the Company issued 150 million British pounds ($181.2 million at December 31, 2022) in aggregate principal amount of 2.59% senior notes due November 2028 and 75 million British pounds ($90.6 million at December 31, 2022) in aggregate principal amount of 2.70% senior notes due November 2031. On May 12, 2022, the Company along with certain of its foreign subsidiaries amended its credit agreement dated as of September 22, 2011, as amended and restated as of March 10, 2016 and as further amended and restated as of October 30, 2018 (the “Credit Agreement”). The Credit Agreement amends and restates the Company’s existing revolving credit facility to increase the size from $1.5 billion to $2.3 billion and terminates the $800 million term loan. The Credit Agreement consists of a five-year revolving credit facility with a final maturity date in May 2027. The revolving credit facility total borrowing capacity excludes an accordion feature that permits the Company to request up to an additional $700 million in revolving credit commitments at any time during the life of the Credit Agreement under certain conditions. The credit agreement places certain restrictions on allowable additional indebtedness. In November 2021, the Company further amended the Credit Agreement to address the cessation of LIBOR on certain currencies. At December 31, 2022, the Company had available borrowing capacity of $2,745.2 million under its revolving credit facility, including the $700 million accordion feature. Interest rates on outstanding borrowings under the revolving credit facility are at the applicable benchmark rate plus a negotiated spread or at the U.S. prime rate. At December 31, 2022 and 2021 the Company had $219.0 million and $314.5 million of borrowings outstanding under the revolving credit facility, respectively. The weighted average interest rate on the revolving credit facility for the years ended December 31, 2022 and 2021 was 3.57% and 1.34%, respectively. The Company had outstanding letters of credit primarily under the revolving credit facility totaling $35.8 million and $38.0 million at December 31, 2022 and 2021, respectively. The private placements, the senior notes and the revolving credit facility are subject to certain customary covenants, including financial covenants that, among other things, require the Company to maintain certain debt-to-EBITDA and interest coverage ratios. The Company was in compliance with all provisions of the debt arrangements at December 31, 2022. Foreign subsidiaries of the Company had available credit facilities with local foreign lenders of $64.1 million and $56.8 million at December 31, 2022 and 2021, respectively. At December 31, 2022, foreign subsidiaries had $11.8 million in debt borrowings outstanding, which was reported in short-term borrowings. At December 31, 2021, foreign subsidiaries had $2.0 million of debt borrowings outstanding. The weighted average interest rate on total debt borrowings outstanding at December 31, 2022 and 2021 was 3.4% and 3.1%, respectively. |
Share-Based Compensation
Share-Based Compensation | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share-Based Compensation | Share-Based Compensation Under the terms of the Company’s stockholder-approved share-based plans, performance restricted stock units (“PRSUs”), incentive and non-qualified stock options and restricted stock have been, and may be, issued to the Company’s officers, management-level employees and members of its Board of Directors. Stock options granted prior to 2018 generally vest at a rate of one-fourth on each of the first four anniversaries of the grant date and have a maximum contractual term of seven years. Beginning in 2018, stock options granted generally vest at a rate of one-third on each of the first three anniversaries of the grant date and have a maximum contractual term of ten years. Restricted stock granted to employees prior to 2018 generally vests four years after the grant date (cliff vesting) and is subject to accelerated vesting due to certain events, including doubling of the grant price of the Company’s common stock as of the close of business during any five consecutive trading days. Beginning in 2018, restricted stock granted to employees generally vests one-third on each of the first three anniversaries of the grant date. Restricted stock granted to non-employee directors generally vests two years after the grant date (cliff vesting) and is subject to accelerated vesting due to certain events, including doubling of the grant price of the Company’s common stock as of the close of business during any five consecutive trading days. Share Based Compensation Expense The Company measures and records compensation expense related to all stock awards by recognizing the grant date fair value of the awards over their requisite service periods in the financial statements. For grants under any of the Company’s plans that are subject to graded vesting based on a service condition, the Company recognizes expense on a straight-line basis over the requisite service period for the entire award. Total share-based compensation expense was as follows for the years ended December 31: 2022 2021 2020 (In thousands) Stock option expense $ 13,021 $ 12,733 $ 13,695 Restricted stock expense 20,115 21,393 17,997 PRSU expense 14,239 11,977 9,873 Total pre-tax expense $ 47,375 $ 46,103 $ 41,565 Pre-tax share-based compensation expense is included in the consolidated statement of income in either Cost of sales or Selling, general and administrative expenses, depending on where the recipient’s cash compensation is reported. Stock Options The fair value of each stock option grant is estimated on the date of grant using a Black-Scholes-Merton option pricing model. The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the years indicated: 2022 2021 2020 Expected volatility 24.5 % 24.2 % 22.2 % Expected term (years) 5.0 5.0 5.0 Risk-free interest rate 2.33 % 0.85 % 0.52 % Expected dividend yield 0.65 % 0.66 % 1.14 % Black-Scholes-Merton fair value per stock option granted $ 32.54 $ 25.63 $ 11.01 Expected volatility is based on the historical volatility of the Company’s stock over the stock options’ expected term. The Company used historical exercise data to estimate the stock options’ expected term, which represents the period of time that the stock options granted are expected to be outstanding. Management anticipates that the future stock option holding periods will be similar to the historical stock option holding periods. The risk-free interest rate for periods within the expected term of the stock option is based on the U.S. Treasury yield curve at the time of grant. The expected dividend yield is calculated by dividing the Company’s annual dividend, based on the most recent quarterly dividend rate, by the Company’s closing common stock price on the grant date. Compensation expense recognized for all share-based awards is net of estimated forfeitures. The Company’s estimated forfeiture rates are based on its historical experience. The following is a summary of the Company’s stock option activity and related information for the year ended December 31, 2022: Shares Weighted Weighted Aggregate (In thousands) (Years) (In millions) Outstanding at the beginning of the year 3,352 $ 76.08 Granted 608 134.69 Exercised (788) 63.75 Forfeited (107) 108.79 Expired (5) 101.38 Outstanding at the end of the year 3,060 $ 79.46 6.5 $ 153.0 Exercisable at the end of the year 1,944 $ 75.00 5.4 $ 125.8 The aggregate intrinsic value of stock options exercised during 2022, 2021 and 2020 was $50.3 million, $59.1 million and $63.7 million, respectively. The total fair value of stock options vested during 2022, 2021 and 2020 was $11.4 million, $13.7 million and $12.9 million, respectively. The following is a summary of the Company’s non-vested stock option activity and related information for the year ended December 31, 2022: Shares Weighted (In thousands) Non-vested stock options outstanding at the beginning of the year 1,292 $ 18.41 Granted 608 32.54 Vested (677) 16.78 Forfeited (107) 23.86 Non-vested stock options outstanding at the end of the year 1,116 $ 26.57 As of December 31, 2022, there was approximately $18 million of expected future pre-tax compensation expense related to the 1.1 million non-vested stock options outstanding, which is expected to be recognized over a weighted average period of less than two years. Restricted Stock The fair value of restricted shares under the Company’s restricted stock arrangement is determined by the product of the number of shares granted and the Company’s closing common stock price on the grant date. Upon the grant of restricted stock, the fair value of the restricted shares (unearned compensation) at the grant date is charged as a reduction of capital in excess of par value in the Company’s consolidated balance sheet and is amortized to expense on a straight-line basis over the vesting period, which is the same as the calculated derived service period as determined on the grant date. The following is a summary of the Company’s non-vested restricted stock activity and related information for the year ended December 31, 2022: Shares Weighted (In thousands) Non-vested restricted stock outstanding at the beginning of the year 413 $ 96.07 Granted 184 134.52 Vested (195) 90.78 Forfeited (46) 109.08 Non-vested restricted stock outstanding at the end of the year 356 $ 117.18 The total fair value of restricted stock vested during 2022, 2021 and 2020 was $17.7 million, $28.6 million and $14.4 million, respectively. The weighted average fair value of restricted stock granted per share during 2022 and 2021 was $134.52 and $122.60, respectively. As of December 31, 2022, there was approximately $27 million of expected future pre-tax compensation expense related to the 0.4 million non-vested restricted shares outstanding, which is expected to be recognized over a weighted average period of less than two years. Performance Restricted Stock Units The PRSUs vest over a period up to three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which the Company achieves certain financial and market performance targets measured over the period from January 1 of the year of grant through December 31 of the third year. Half of the PRSUs are valued in a manner similar to restricted stock as the financial targets are based on the Company’s operating results. The grant date fair value of these PRSUs are recognized as compensation expense over the vesting period based on the number of awards expected to vest at each reporting date. The other half of the PRSUs were valued using a Monte Carlo model as the performance target is related to the Company’s total shareholder return compared to a group of peer companies, which represents a market condition. The Company recognizes the grant date fair value of these awards as compensation expense ratably over the vesting period. The following is a summary of the Company’s non-vested performance restricted stock activity and related information for the year ended December 31, 2022: Shares Weighted (In thousands) Non-vested performance restricted stock outstanding at the beginning of the year 289 $ 85.29 Granted 87 134.69 Performance assumption change 1 66 81.76 Vested (161) 81.76 Forfeited (6) 98.07 Non-vested performance restricted stock outstanding at the end of the year 275 $ 101.98 _________________________________________ 1 Reflects the number of PRSUs above target levels based on performance metrics. As of December 31, 2022, there was approximately $4 million of expected future pre-tax compensation expense related to the 0.3 million non-vested performance restricted shares outstanding, which is expected to be recognized over a weighted average period of less than one year. The Company issues previously unissued shares when stock options are exercised, and shares are issued from treasury stock upon the award of restricted stock. |
Retirement Plans and Other Post
Retirement Plans and Other Postretirement Benefits | 12 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Retirement Plans and Other Postretirement Benefits | Retirement Plans and Other Postretirement Benefits Retirement and Pension Plans The Company sponsors several retirement and pension plans covering eligible salaried and hourly employees. The plans generally provide benefits based on participants’ years of service and/or compensation. The following is a brief description of the Company’s retirement and pension plans. The Company maintains contributory and non-contributory defined benefit pension plans. Benefits for eligible salaried and hourly employees under all defined benefit plans are funded through trusts established in conjunction with the plans. The Company’s funding policy with respect to its defined benefit plans is to contribute amounts that provide for benefits based on actuarial calculations and the applicable requirements of U.S. federal and local foreign laws. The Company estimates that it will make both required and discretionary cash contributions of approximately $7 million to $11 million to its worldwide defined benefit pension plans in 2023. The Company uses a measurement date of December 31 (its fiscal year end) for its U.S. and foreign defined benefit pension plans. The Company sponsors a 401(k) retirement and savings plan for eligible U.S. employees. Participants in the retirement and savings plan may contribute a specified portion of their compensation on a pre-tax basis, which varies by location. The Company matches employee contributions ranging from 20% to 100%, up to a maximum percentage ranging from 1% to 8% of eligible compensation or up to a maximum of $1,200 per participant in some locations. The Company’s retirement and savings plan has a defined contribution retirement feature principally to cover U.S. salaried employees joining the Company after December 31, 1996. Under the retirement feature, the Company makes contributions for eligible employees based on a pre-established percentage of the covered employee’s salary subject to pre-established vesting. Employees of certain of the Company’s foreign operations participate in various local defined contribution plans. The Company has non-qualified unfunded retirement plans for certain Directors and retired employees. It also provides supplemental retirement benefits, through contractual arrangements and/or a Supplemental Executive Retirement Plan (“SERP”) covering certain current and former executives of the Company. These supplemental benefits are designed to compensate the executive for retirement benefits that would have been provided under the Company’s primary retirement plan, except for statutory limitations on compensation that must be taken into account under those plans. The projected benefit obligations of the SERP and the contracts will primarily be funded by a grant of shares of the Company’s common stock upon retirement or termination of the executive. The Company is providing for these obligations by charges to earnings over the applicable periods. The following tables set forth the changes in net projected benefit obligation and the fair value of plan assets for the funded and unfunded defined benefit plans for the years ended December 31: U.S. Defined Benefit Pension Plans: 2022 2021 (In thousands) Change in projected benefit obligation: Net projected benefit obligation at the beginning of the year $ 504,773 $ 532,357 Service cost 2,067 2,767 Interest cost 14,889 14,074 Actuarial (gains) losses (106,159) (12,593) Gross benefits paid (32,090) (31,832) Acquisition (337) — Net projected benefit obligation at the end of the year $ 383,143 $ 504,773 Change in plan assets: Fair value of plan assets at the beginning of the year $ 701,627 $ 662,298 Actual return on plan assets (101,381) 70,540 Employer contributions 1,230 621 Gross benefits paid (32,090) (31,832) Acquisition (337) — Fair value of plan assets at the end of the year $ 569,049 $ 701,627 Foreign Defined Benefit Pension Plans: 2022 2021 (In thousands) Change in projected benefit obligation: Net projected benefit obligation at the beginning of the year $ 332,422 $ 351,584 Service cost 2,852 4,218 Interest cost 5,235 4,458 Foreign currency translation adjustments (31,367) (6,580) Employee contributions — 76 Actuarial (gains) losses (100,201) (10,199) Expenses paid from assets (686) (1,121) Gross benefits paid (9,409) (10,426) Settlements (102) — Curtailments — 412 Net projected benefit obligation at the end of the year $ 198,744 $ 332,422 Change in plan assets: Fair value of plan assets at the beginning of the year $ 266,288 $ 250,735 Actual return on plan assets (77,643) 20,184 Employer contributions 7,729 9,656 Employee contributions — 76 Foreign currency translation adjustments (26,585) (2,816) Expenses paid from assets (686) (1,121) Settlements (102) — Gross benefits paid (9,409) (10,426) Fair value of plan assets at the end of the year $ 159,592 $ 266,288 The projected benefit obligation assumptions impacting net actuarial losses (gains) primarily consist of changes in discount and mortality rates. A significant component of the actuarial gains in 2022 for both the U.S. and Foreign Defined Benefit Plans was the increase in discount rates. The accumulated benefit obligation consisted of the following at December 31: U.S. Defined Benefit Pension Plans: 2022 2021 (In thousands) Funded plans $ 374,979 $ 492,957 Unfunded plans 2,869 3,913 Total $ 377,848 $ 496,870 Foreign Defined Benefit Pension Plans: 2022 2021 (In thousands) Funded plans $ 167,495 $ 284,013 Unfunded plans 30,924 47,761 Total $ 198,419 $ 331,774 Weighted average assumptions used to determine benefit obligations at December 31: 2022 2021 U.S. Defined Benefit Pension Plans: Discount rate 5.65 % 3.02 % Rate of compensation increase (where applicable) 3.75 % 3.75 % Foreign Defined Benefit Pension Plans: Discount rate 4.73 % 1.78 % Rate of compensation increase (where applicable) 2.50 % 2.50 % The following is a summary of the fair value of plan assets for U.S. plans at December 31: 2022 2021 Asset Class Total Level 1 Level 2 Total Level 1 Level 2 (In thousands) Corporate debt instruments $ 6,192 $ — $ 6,192 $ 4,053 $ — $ 4,053 Corporate debt instruments – Preferred 13,425 — 13,425 11,265 — 11,265 Corporate stocks – Common 53,629 53,629 — 67,975 67,975 — Municipal bonds 711 — 711 676 — 676 Registered investment companies 155,541 155,541 — 150,535 150,535 — U.S. Government securities 1,253 — 1,253 663 — 663 Total investments 230,751 209,170 21,581 235,167 218,510 16,657 Investments measured at net asset value 338,298 — — 466,460 — — Total investments $ 569,049 $ 209,170 $ 21,581 $ 701,627 $ 218,510 $ 16,657 U.S. equity securities and global equity securities categorized as level 1 are traded on national and international exchanges and are valued at their closing prices on the last trading day of the year. Some U.S. equity securities and global equity securities are public investment vehicles valued using the Net Asset Value (“NAV”) provided by the fund manager. The NAV is the total value of the fund divided by the number of shares outstanding. Fixed income securities categorized as level 2 are valued by the trustee using pricing models that use verifiable observable market data, bids provided by brokers or dealers or quoted prices of securities with similar characteristics. The expected long-term rate of return on these plan assets was 6.75% in 2022 and 6.75% in 2021. Equity securities included 352,601 shares of AMETEK, Inc. common stock with a market value of $49.3 million (8.7% of total plan investment assets) at December 31, 2022 and 384,788 shares of AMETEK, Inc. common stock with a market value of $56.6 million (8.1% of total plan investment assets) at December 31, 2021. The objectives of the Company’s U.S. defined benefit plans’ investment strategy are to maximize the plans’ funded status and minimize Company contributions and plan expense. Because the goal is to optimize returns over the long term, an investment policy that favors equity holdings has been established. Since there may be periods of time where both equity and mutual fund markets provide poor returns, an allocation to alternative assets may be made to improve the overall portfolio’s diversification and return potential. The Company periodically reviews its asset allocation, taking into consideration plan liabilities, plan benefit payment streams and the investment strategy of the pension plans. The actual asset allocation is monitored frequently relative to the established targets and ranges and is re-balanced when necessary. The target allocations for the U.S. defined benefits plans are approximately 50% equity securities, 20% fixed income securities and 30% other securities and/or cash. The equity portfolio is diversified by market capitalization and style. The equity portfolio also includes international components. The objective of the mutual fund portion of the pension assets is to provide interest rate sensitivity for a portion of the assets and to provide diversification. The mutual fund portfolio is diversified within certain quality and maturity guidelines to minimize the adverse effects of interest rate fluctuations. Certain investments are prohibited and include venture capital, private placements, unregistered or restricted stock, margin trading, commodities, short selling and rights and warrants. Foreign currency futures, options and forward contracts may be used to manage foreign currency exposure. The following is a summary of the fair value of plan assets for foreign defined benefit pension plans at December 31: 2022 2021 Asset Class Total Level 3 Total Level 3 (In thousands) Life insurance $ 13,043 $ 13,043 $ 18,806 $ 18,806 Total investments 13,043 13,043 18,806 18,806 Investments measured at net asset value 146,549 — 247,482 — Total investments $ 159,592 $ 13,043 $ 266,288 $ 18,806 Life insurance assets are considered level 3 investments as their values are determined by the sponsor using unobservable market data. Life insurance assets categorized as level 3 are valued based on unobservable inputs and cannot be corroborated using verifiable observable market data. Investments in level 3 funds are redeemable, however, cash reimbursement may be delayed, or a portion held back until asset finalization. The following is a summary of the changes in the fair value of the foreign plans’ level 3 investments (fair value determined using significant unobservable inputs): Life Insurance (In thousands) Balance, December 31, 2020 $ 20,908 Actual return on assets: Unrealized losses relating to instruments still held at the end of the year $ (2,102) Realized gains (losses) relating to assets sold during the year $ — Purchases, sales, issuances and settlements, net $ — Balance, December 31, 2021 $ 18,806 Actual return on assets: Unrealized gains (losses) relating to instruments still held at the end of the year $ (5,763) Realized gains (losses) relating to assets sold during the year $ — Purchases, sales, issuances and settlements, net $ — Balance, December 31, 2022 $ 13,043 The objective of the Company’s foreign defined benefit plans’ investment strategy is to maximize the long-term rate of return on plan investments, subject to a reasonable level of risk. Liability studies are also performed on a regular basis to provide guidance in setting investment goals with an objective to balance risks against the current and future needs of the plans. The trustees consider the risk associated with the different asset classes, relative to the plans’ liabilities and how this can be affected by diversification, and the relative returns available on equities, mutual fund investments, real estate and cash. Also, the likely volatility of those returns and the cash flow requirements of the plans are considered. It is expected that equities will outperform mutual fund investments over the long term. However, the trustees recognize the fact that mutual fund investments may better match the liabilities for pensioners. Because of the relatively young active employee group covered by the plans and the immature nature of the plans, the trustees have chosen to adopt an asset allocation strategy more heavily weighted toward equity investments. This asset allocation strategy will be reviewed, from time to time, in view of changes in market conditions and in the plans’ liability profile. The target allocations for the foreign defined benefit plans are approximately 23% equity securities, 21% fixed income securities, 51% multi-asset funds and 5% other securities, insurance or cash. The assumption for the expected return on plan assets was developed based on a review of historical investment returns for the investment categories for the defined benefit pension assets. This review also considered current capital market conditions and projected future investment returns. The estimates of future capital market returns by asset class are lower than the actual long-term historical returns. Therefore, the assumed rate of return for U.S. plans is 7.59% and 6.41% for foreign plans in 2023. The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with a projected benefit obligation in excess of plan assets and pension plans with an accumulated benefit obligation in excess of plan assets were as follows at December 31: U.S. Defined Benefit Pension Plans: Projected Benefit Accumulated Benefit 2022 2021 2022 2021 (In thousands) Benefit obligation $ 4,043 $ 6,234 $ 4,043 $ 6,234 Fair value of plan assets 707 1,239 707 1,239 Foreign Defined Benefit Pension Plans: Projected Benefit Accumulated Benefit 2022 2021 2022 2021 (In thousands) Benefit obligation $ 162,105 $ 272,245 $ 161,780 $ 271,596 Fair value of plan assets 120,056 200,862 120,056 200,862 The following table provides the amounts recognized in the consolidated balance sheet at December 31: 2022 2021 (In thousands) Funded status asset (liability): Fair value of plan assets $ 728,641 $ 967,915 Projected benefit obligation (581,887) (837,195) Funded status at the end of the year $ 146,754 $ 130,720 Amounts recognized in the consolidated balance sheet consisted of: Non-current asset for pension benefits (other assets) $ 192,140 $ 207,099 Current liabilities for pension benefits (2,700) (2,133) Non-current liability for pension benefits (42,686) (74,246) Net amount recognized at the end of the year $ 146,754 $ 130,720 The following table provides the amounts recognized in accumulated other comprehensive income, net of taxes, at December 31: Net amounts recognized: 2022 2021 (In thousands) Net actuarial loss $ 205,193 $ 193,220 Prior service costs 1,625 1,855 Transition asset 3 4 Total recognized $ 206,821 $ 195,079 The following table provides the components of net periodic pension benefit expense (income) for the years ended December 31: 2022 2021 2020 (In thousands) Defined benefit plans: Service cost $ 4,919 $ 6,985 $ 7,261 Interest cost 20,124 18,532 22,611 Expected return on plan assets (60,104) (56,752) (54,629) Curtailment — 3,151 — Settlement (58) — — Amortization of: Net actuarial loss 8,531 16,353 15,479 Prior service costs 100 456 486 Transition asset 1 1 1 Total net periodic benefit income (26,487) (11,274) (8,791) Other plans: Defined contribution plans 39,326 31,149 30,829 Foreign plans and other 8,373 8,454 7,902 Total other plans 47,699 39,603 38,731 Total net pension expense $ 21,212 $ 28,329 $ 29,940 The total net periodic benefit expense (income) is included in Cost of sales, General and administrative expense and Other income and expense The following weighted average assumptions were used to determine the above net periodic pension benefit income for the years ended December 31: 2022 2021 2020 U.S. Defined Benefit Pension Plans: Discount rate 3.02 % 2.69 % 3.45 % Expected return on plan assets 6.75 % 6.75 % 7.00 % Rate of compensation increase (where applicable) 3.75 % 3.75 % 3.75 % Foreign Defined Benefit Pension Plans: Discount rate 1.78 % 1.27 % 1.83 % Expected return on plan assets 5.85 % 5.47 % 5.97 % Rate of compensation increase (where applicable) 2.50 % 2.50 % 2.50 % Estimated Future Benefit Payments The estimated future benefit payments for U.S. and foreign plans are as follows: 2023 – $42.7 million; 2024 – $43.3 million; 2025 – $42.9 million; 2026 – $42.8 million; 2027 – $42.4 million; 2028 to 2032 - $208.3 million. Future benefit payments primarily represent amounts to be paid from pension trust assets. Amounts included that are to be paid from the Company’s assets are not significant in any individual year. Postretirement Plans and Post-employment Benefits The Company provides limited postretirement benefits other than pensions for certain retirees and a small number of former employees. Benefits under these arrangements are not funded and are not significant. The Company also provides limited post-employment benefits for certain former or inactive employees after employment but before retirement. Those benefits are not significant in amount. The Company has a deferred compensation plan, which allows employees whose compensation exceeds the statutory IRS limit for retirement benefits to defer a portion of earned bonus compensation. The plan permits deferred amounts to be deemed invested in either, or a combination of, (a) an interest-bearing account, benefits from which are payable out of the general assets of the Company, or (b) the equivalent of a fund which invests in shares of the Company’s common stock on behalf of the employee. The amount deferred under the plan, including income earned, was $31.8 million and $28.4 million at December 31, 2022 and 2021, respectively. Administrative expense for the deferred compensation plan is borne by the Company and is not significant. |
Contingencies
Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies | Contingencies Indemnifications In conjunction with certain acquisition and divestiture transactions, the Company may agree to make payments to compensate or indemnify other parties for possible future unfavorable financial consequences resulting from specified events (e.g., breaches of contract obligations or retention of previously existing environmental, tax or employee liabilities) whose terms range in duration and often are not explicitly defined. Where appropriate, the obligation for such indemnifications is recorded as a liability. Because the amount of these types of indemnifications generally is not specifically stated, the overall maximum amount of the obligation under such indemnifications cannot be reasonably estimated. Further, the Company indemnifies its directors and officers for claims against them in connection with their positions with the Company. Historically, any such costs incurred to settle claims related to these indemnifications have been minimal for the Company. The Company believes that future payments, if any, under all existing indemnification agreements would not have a material impact on its consolidated results of operations, financial position or cash flows. Asbestos Litigation The Company (including its subsidiaries) has been named as a defendant in a number of asbestos-related lawsuits. Certain of these lawsuits relate to a business which was acquired by the Company and do not involve products which were manufactured or sold by the Company. In connection with these lawsuits, the seller of such business has agreed to indemnify the Company against these claims (the “Indemnified Claims”). The Indemnified Claims have been tendered to, and are being defended by, such seller. The seller has met its obligations, in all respects, and the Company does not have any reason to believe such party would fail to fulfill its obligations in the future. To date, no judgments have been rendered against the Company as a result of any asbestos-related lawsuit. The Company believes that it has good and valid defenses to each of these claims and intends to defend them vigorously. Environmental Matters Certain historic processes in the manufacture of products have resulted in environmentally hazardous waste by-products as defined by federal and state laws and regulations. At December 31, 2022, the Company is named a Potentially Responsible Party (“PRP”) at 13 non-AMETEK-owned former waste disposal or treatment sites (the “non-owned”sites). The Company is identified as a “de minimis” party in 12 of these sites based on the low volume of waste attributed to the Company relative to the amounts attributed to other named PRPs. In eight of these sites, the Company has reached a tentative agreement on the cost of the de minimis settlement to satisfy its obligation and is awaiting executed agreements. The tentatively agreed-to settlement amounts are fully accrued. In the other four sites, the Company is continuing to investigate the accuracy of the alleged volume attributed to the Company as estimated by the parties primarily responsible for remedial activity at the sites to establish an appropriate settlement amount. At the remaining site where the Company is a non-de minimis PRP, the Company is participating in the investigation and/or related required remediation as part of a PRP Group and reserves have been established sufficient to satisfy the Company’s expected obligations. The Company historically has resolved these issues within established reserve levels and reasonably expects this result will continue. In addition to these non-owned sites, the Company has an ongoing practice of providing reserves for probable remediation activities at certain of its current or previously owned manufacturing locations (the “owned” sites). For claims and proceedings against the Company with respect to other environmental matters, reserves are established once the Company has determined that a loss is probable and estimable. This estimate is refined as the Company moves through the various stages of investigation, risk assessment, feasibility study and corrective action processes. In certain instances, the Company has developed a range of estimates for such costs and has recorded a liability based on the best estimate. It is reasonably possible that the actual cost of remediation of the individual sites could vary from the current estimates and the amounts accrued in the consolidated financial statements; however, the amounts of such variances are not expected to result in a material change to the consolidated financial statements. In estimating the Company’s liability for remediation, the Company also considers the likely proportionate share of the anticipated remediation expense and the ability of the other PRPs to fulfill their obligations. Total environmental reserves at December 31, 2022 and 2021 were $41.0 million and $37.2 million, respectively, for both non-owned and owned sites. In 2022, the Company recorded $12.0 million in reserves. Additionally, in 2022 the Company spent $8.2 million on environmental matters. The Company has agreements with other former owners of certain of its acquired businesses, as well as new owners of previously owned businesses. Under certain of the agreements, the former or new owners retained, or assumed and agreed to indemnify the Company against, certain environmental and other liabilities under certain circumstances. The Company and some of these other parties also carry insurance coverage for some environmental matters. |
Leases and Other Commitments
Leases and Other Commitments | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases and Other Commitments | Leases and Other Commitments Leases The Company has commitments under operating leases for certain facilities, vehicles and equipment used in its operations. Our leases have initial lease terms ranging from 1 month to 15 years. The components of lease expense were as follows: 2022 2021 2020 (In thousands) Operating lease cost $ 59,296 $ 61,680 $ 44,498 Variable lease cost 11,096 7,724 4,526 Total lease cost $ 70,392 $ 69,404 $ 49,024 Supplemental balance sheet information related to leases was as follows: December 31, 2022 2021 (In thousands) Right of use assets, net $ 170,295 $ 169,924 Lease liabilities included in Accrued liabilities and other 46,366 47,353 Lease liabilities included in Other long-term liabilities 129,227 129,101 Total lease liabilities $ 175,593 $ 176,454 Supplemental cash flow information and other information related to leases was as follows for the year ended December 31: 2022 2021 (In thousands) Cash used in operations for operating leases $ 54,724 $ 55,657 Right-of-use assets obtained in exchange for new operating liabilities $ 59,802 $ 64,653 Weighted-average remaining lease terms – operating leases (years) 5.07 5.36 Weighted-average discount rate – operating leases 3.32 % 2.91 % Maturities of lease liabilities as of December 31, 2022 were as follows: Lease Liability Maturity Analysis Operating Leases (In thousands) 2023 $ 51,740 2024 41,047 2025 31,338 2026 23,770 2027 15,467 Thereafter 29,523 Total lease payments 192,885 Less: imputed interest 17,292 $ 175,593 The Company does not have any significant leases that have not yet commenced. Other Commitments As of December 31, 2022, and 2021, the Company had $1,119.7 million and $890.9 million, respectively, in purchase obligations outstanding, which primarily consisted of contractual commitments to purchase certain inventories at fixed prices. |
Reportable Segments and Geograp
Reportable Segments and Geographic Areas Information | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Reportable Segments and Geographic Areas Information | Reportable Segments and Geographic Areas Information Descriptive Information about Reportable Segments The Company has two reportable segments, EIG and EMG. The Company’s operating segments are identified based on the existence of segment managers. Certain of the Company’s operating segments have been aggregated for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and similarity of economic characteristics. EIG manufactures advanced instruments for the process, power and industrial, and aerospace markets. It provides process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries. EIG also provides instruments to the laboratory equipment, ultra- precision manufacturing, medical, and test and measurement markets. It makes power quality monitoring and metering devices, uninterruptible power supplies, programmable power equipment, electromagnetic compatibility test equipment and gas turbines sensors. EIG also provides dashboard instruments for heavy trucks and other vehicles, as well as instrumentation and controls for the food and beverage industries. It supplies the aerospace industry with aircraft and engine sensors, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition systems. EMG is a differentiated supplier of automation solutions, thermal management systems, specialty metals and electrical interconnects. It manufactures highly engineered electrical connectors and electronic packaging used to protect sensitive electronic devices. EMG also makes precision motion control products for data storage, medical devices, business equipment, automation and other applications. It supplies high-purity powdered metals, strip and foil, specialty clad metals and metal matrix composites. EMG also manufactures motors used in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps and industrial blowers. It produces motor-blower systems and heat exchangers used in thermal management and other applications on a variety of military and commercial aircraft and military ground vehicles. EMG also operates a global network of aviation maintenance, repair and overhaul facilities. Measurement of Segment Results Segment operating income represents net sales less all direct costs and expenses (including certain administrative and other expenses) applicable to each segment but does not include interest expense. Net sales by segment are reported after elimination of intra- and inter-segment sales and profits, which are insignificant in amount. Reported segment assets include allocations directly related to the segment’s operations. Corporate assets consist primarily of investments, pensions, insurance deposits and deferred taxes. Reportable Segment Financial Information 2022 2021 2020 (In thousands) Operating income and income before income taxes: Segment operating income: Electronic Instruments $ 1,089,729 $ 958,183 $ 770,620 Electromechanical 503,593 437,378 324,962 Total segment operating income 1,593,322 1,395,561 1,095,582 Corporate administrative expenses (92,630) (86,891) (67,698) Consolidated operating income 1,500,692 1,308,670 1,027,884 Interest and other income (expenses), net (72,000) (85,500) 54,425 Consolidated income before income taxes $ 1,428,692 $ 1,223,170 $ 1,082,309 Assets: Electronic Instruments $ 9,430,797 $ 8,672,711 Electromechanical 2,617,685 2,638,773 Total segment assets 12,048,482 11,311,484 Corporate 382,638 586,703 Consolidated assets $ 12,431,120 $ 11,898,187 2022 2021 2020 (In thousands) Additions to property, plant and equipment (1) : Electronic Instruments $ 93,505 $ 168,267 $ 48,638 Electromechanical 38,186 34,586 26,381 Total segment additions to property, plant and equipment 131,691 202,853 75,019 Corporate 19,757 10,417 1,007 Consolidated additions to property, plant and equipment $ 151,448 $ 213,270 $ 76,026 Depreciation and amortization: Electronic Instruments $ 238,436 $ 210,118 $ 174,494 Electromechanical 77,896 79,497 78,297 Total segment depreciation and amortization 316,332 289,615 252,791 Corporate 3,095 2,497 2,484 Consolidated depreciation and amortization $ 319,427 $ 292,112 $ 255,275 ___________________ (1) Includes $12.4 million in 2022, $102.6 million in 2021 and $1.8 million in 2020 from acquired businesses. Geographic Areas Information about the Company’s operations in different geographic areas for the years ended December 31, 2022 and 2021 is shown below. 2022 2021 (In thousands) Long-lived assets from continuing operations (excluding intangible assets): United States $ 412,577 $ 416,323 International (1) : United Kingdom 71,462 74,525 European Union countries 89,993 87,117 Asia 11,479 11,971 Other foreign countries 50,130 27,202 Total international 223,064 200,815 Total consolidated $ 635,641 $ 617,138 _________________ (1) Represents long-lived assets of foreign-based operations only. |
Additional Consolidated Income
Additional Consolidated Income Statement and Cash Flow Information | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Additional Consolidated Income Statement and Cash Flow Information | Additional Consolidated Income Statement and Cash Flow Information Included in other income (expense), net are interest and other investment income of $1.0 million, $2.0 million and $2.7 million for 2022, 2021 and 2020, respectively. Income taxes paid in 2022, 2021 and 2020 were $299.3 million, $245.5 million and $210.4 million, respectively. Cash paid for interest was $80.2 million, $78.7 million and $86.2 million in 2022, 2021 and 2020, respectively. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders’ Equity In 2021, the Company repurchased approximately 113,000 shares of its common stock for $14.7 million in cash under its share repurchase authorization. On May 5, 2022, the Company's Board of Directors approved a $1 billion authorization of its common stock, which replaced the previous $500 million authorization announced in February 2019. In 2022, the Company repurchased approximately 2.7 million shares of its common stock for $332.8 million in cash under its share repurchase authorization. At December 31, 2022, $823.9 million was available under the Company’s Board of Directors authorization for future share repurchases. Effective February 9, 2022, the Company’s Board of Directors approved a 10% increase in the quarterly cash dividend on the Company’s common stock to $0.22 per common share from $0.20 per common share. At December 31, 2022, the Company held 38.5 million shares in its treasury at a cost of $1,903.0 million, compared with 36.1 million shares at a cost of $1,573.0 million at December 31, 2021. The number of shares outstanding at December 31, 2022 was 230.1 million shares, compared with 231.7 million shares at December 31, 2021. Subsequent Event Effective February 9, 2023, the Company’s Board of Directors approved a 14% increase in the quarterly cash dividend on the Company’s common stock to $0.25 per common share from $0.22 per common share. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Consolidation | Basis of Consolidation The accompanying consolidated financial statements reflect the results of operations, financial position and cash flows of AMETEK, Inc. (the “Company”), and include the accounts of the Company and subsidiaries, after elimination of all intercompany transactions in the consolidation. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates and assumptions. |
Cash Equivalents, Securities and Other Investments | Cash Equivalents, Securities and Other Investments All highly liquid investments with maturities of three months or less when purchased are considered cash equivalents. |
Accounts Receivable | Accounts Receivable The Company maintains allowances for estimated credit losses resulting from the inability of customers to meet their financial obligations to the Company. The Company recognizes an allowance for credit losses, on all accounts receivable and contract assets, which considers risk of future credit losses based on factors such as historical experience, contract terms, as well as general and market business conditions, country, and political risk. Balances are written off when considered uncollectible. Bad debt expense was $3.7 million in 2022, $1.2 million in 2021 and $3.6 million in 2020. At December 31, 2022 and 2021, the allowance for estimated credit losses was $14.1 million and $11.2 million, respectively. |
Inventories | Inventories The Company uses the first-in, first-out (“FIFO”) method of accounting, which approximates current replacement cost, for approximately 90% of its inventories at December 31, 2022. The last-in, first-out (“LIFO”) method of accounting is used to determine cost for the remaining 10% of the Company’s inventory at December 31, 2022. For inventories where cost is determined by the LIFO method, the FIFO value would have been $40.3 million and $29.8 million higher than the LIFO value reported in the consolidated balance sheet at December 31, 2022 and 2021, respectively. The Company provides estimated inventory reserves for slow-moving and obsolete inventory based on current assessments about future demand, market conditions, customers who may be experiencing financial difficulties and related management initiatives. |
Business Combinations | Business Combinations The Company allocates the purchase price of an acquired company, including when applicable, the acquisition date fair value of contingent consideration between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values, with the residual of the purchase price recorded as goodwill. The results of operations of the acquired business are included in the Company’s operating results from the date of acquisition. |
Property, Plant and Equipment | Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for additions to plant facilities, or that extend their useful lives, are capitalized. The cost of minor tools, jigs and dies, and maintenance and repairs is charged to expense as incurred. Depreciation of plant and equipment is calculated principally on a straight-line basis over the estimated useful lives of the related assets. The range of lives for depreciable assets is generally three five |
Goodwill and Other Intangible Assets | Goodwill and Other Intangible Assets Goodwill and other intangible assets with indefinite lives, primarily trademarks and trade names, are not amortized; rather, they are tested for impairment at least annually. The Company identifies its reporting units at the component level, which is one level below its operating segments. Generally, goodwill arises from acquisitions of specific operating companies and is assigned to the reporting unit in which the operating company resides. The Company’s reporting units are divisions that are one level below its operating segments and for which discrete financial information is prepared and regularly reviewed by segment management. When testing goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the estimated fair value of a reporting unit is less than its carrying amount. If the Company performs a qualitative assessment and determines that an impairment is more likely than not, then performance of a quantitative impairment test is required. In conducting a qualitative assessment, the Company analyzes actual and forecasted net sales and selling profit for each reporting unit, as well as historical performance and the results of prior quantitative tests performed. Additionally, the Company assesses critical areas that may impact its business, including macroeconomic conditions, industry and market conditions, cost factors, or any relevant events and factors that may impact projected financial results. If performed, the quantitative goodwill impairment test is performed using a discounted cash flow analysis to determine the fair value of each reporting unit, which considers cash flows discounted at an appropriate discount rate. The annual goodwill impairment test requires the Company to make a number of assumptions and estimates concerning future levels of revenue growth, operating margins, depreciation, amortization and working capital requirements, which are based on the Company’s long-range plan and are considered level 3 inputs. The discount rate is an estimate of the overall after-tax rate of return required by a market participant whose weighted average cost of capital includes both equity and debt, including a risk premium. While the Company uses the best available information to prepare its cash flow and discount rate assumptions, actual future cash flows or market conditions could differ significantly resulting in future impairment charges related to recorded goodwill balances. During the fourth quarter of 2022, the Company completed its annual goodwill impairment tests and elected to perform a qualitative assessment. The impairment test for indefinite-lived intangibles other than goodwill (primarily trademarks and trade names) consists of a comparison of the estimated fair value of the indefinite-lived intangible asset to the carrying value of the asset as of the impairment testing date. The Company estimates the fair value of its indefinite-lived intangibles using the relief from royalty method using level 3 inputs for revenue growth rates and royalty rates. The fair value derived from the relief from royalty method is measured as the discounted cash flow savings realized from owning such trademarks and trade names and not having to pay a royalty for their use. The Company completed its required annual impairment tests in the fourth quarter of 2022, 2021, and 2020 and determined that the carrying values of the Company's goodwill were not impaired. The Company completed its required annual indefinite-lived intangibles impairment test as of October 1, 2022 and determined that the carrying values of certain of the Company's trademarks and trade names with indefinite lives were impaired as a result of higher discount rates driven by higher interest rates. As a result, during the fourth quarter of 2022, the Company recorded an immaterial non-cash impairment charge related to certain of the Company's trade names. The Company completed its required annual impairment tests in the fourth quarter of 2021 and 2020 and determined that the carrying values of the Company's other intangible assets with indefinite lives were not impaired. nine ten |
Financial Instruments and Foreign Currency Translation | Financial Instruments and Foreign Currency Translation Assets and liabilities of foreign operations are translated using exchange rates in effect at the balance sheet date and their results of operations are translated using average exchange rates for the year. Certain transactions of the Company and its subsidiaries are denominated in currencies other than their functional currency. Exchange gains and losses from those transactions are included in operating results for the year. The Company makes infrequent use of derivative financial instruments. Forward contracts are primarily entered into from time to time to hedge debt or foreign currency transactions, thereby minimizing the Company’s exposure to foreign currency fluctuation. |
Leases | Leases The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. The Company has lease agreements which include lease and non-lease components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable. Operating leases are included in right-of-use ("ROU") assets, accrued liabilities and other, and other long-term liabilities on our consolidated balance sheets. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company has no finance leases. The Company primarily leases buildings (real estate) and automobiles which are classified as operating leases. The lease term for all of the Company’s leases includes the non-cancellable period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company’s leases as the reasonably certain threshold is not met. Lease payments included in the measurement of the lease liability are comprised of fixed and variable payments that depend on an index or rate. Variable lease payments not dependent on a rate or index associated with the Company’s leases are recognized when the events, activities, or circumstances in the lease agreement on which those payments are |
Revenue Recognition | Revenue Recognition Revenue is derived from sales of products and services. The Company’s products and services are marketed and sold worldwide through two operating groups: EIG and EMG. See Note 15 Descriptive Information about Reportable Segments. The majority of the Company’s revenues on product sales were recognized at a point in time when the customer obtains control of the product. The transfer in control of the product to the customer was typically evidenced by one or more of the following: the customer having legal title to the product, the Company’s present right to payment, the customer’s physical possession of the product, the customer accepting the product, or the customer having the benefits of ownership or risk of loss. For a small percentage of sales where title and risk of loss transfers at the point of delivery, the Company recognized revenue upon delivery to the customer, which is the point that control transferred, assuming all other criteria for revenue recognition were met. The Company determined that revenues from certain of its customer contracts met the criteria of satisfying its performance obligations over time, primarily in the areas of the manufacture of custom-made equipment and for service repairs of customer-owned equipment. Recognizing revenue over time for custom-manufactured equipment is based on the Company’s judgment that, in certain contracts, the product does not have an alternative use and the Company has an enforceable right to payment for performance completed to date. The Company recognizes incremental cost of obtaining contracts as an expense when incurred if the amortization period of the contract cost assets that the Company would have otherwise recognized is one year or less. These costs are included in Selling, general and administrative expenses in the consolidated statement of income. The determination of the revenue to be recognized in each period for performance obligations satisfied over time is based on the input method. The Company recognizes revenue over time as it performs on these contracts because the transfer of control to the customer occurs over time. Revenue is recognized based on the extent of progress towards completion of the performance obligation. The Company generally uses the total cost-to-cost input method of progress because it best depicts the transfer of control to the customer that occurs as costs are incurred. Under the cost-to-cost method, the extent of progress towards completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. On certain contracts, labor hours are used as the measure of progress when it is determined to be a better depiction of the transfer of control to the customer due to the timing and pattern of labor hours incurred. Performance obligations also include post-delivery service, installation and training. Post-delivery service revenues are recognized over the contract term. Installation and training revenues are recognized over the period the service is provided. Warranty terms in customer contracts can also be considered separate performance obligations if the warranty provides services beyond assurance that a product complies with agreed-upon specification or if a warranty can be purchased separately. The Company does not incur significant obligations for customer returns and refunds. The Company has certain contracts with variable consideration in the form of volume discounts, rebates and early payment options, which may affect the transaction price used as the basis for revenue recognition. In these contracts, the amount of the variable consideration is allocated among the various performance obligations in the customer contract based on the relative standalone selling price of each performance obligation to the total standalone value of all the performance obligations. |
Research and Development | Research and Development Research and development costs are included in Cost of sales as incurred and were $198.8 million in 2022, $194.2 million in 2021 and $158.9 million in 2020. |
Shipping and Handling Costs | Shipping and Handling Costs Shipping and handling costs are included in Cost of sales and were $103.7 million in 2022, $86.1 million in 2021 and $56.8 million in 2020. |
Share-Based Compensation | Share-Based Compensation The Company expenses the fair value of share-based awards made under its share-based plans in the consolidated financial statements over their requisite service period of the grants. |
Income Taxes | Income Taxes The Company conducts a broad range of operations around the world and is therefore subject to complex tax regulations in numerous international taxing jurisdictions, resulting at times in tax audits, disputes and potential litigation, the outcome of which is uncertain. Management must make judgments currently about such uncertainties and determine estimates of the Company’s tax assets and liabilities. To the extent the final outcome differs, future adjustments to the Company’s tax assets and liabilities may be necessary. The Company assesses the realizability of its deferred tax assets, taking into consideration the Company’s forecast of future taxable income, available net operating loss carryforwards and available tax planning strategies that could be implemented to realize the deferred tax assets. Based on this assessment, management must evaluate the need for, and amount of, valuation allowances against the Company’s deferred tax assets. To the extent facts and circumstances change in the future, adjustments to the valuation allowances may be required. The Company assesses the uncertainty in its tax positions, by applying a minimum recognition threshold which a tax position is required to meet before a tax benefit is recognized in the financial statements. Once the minimum threshold is met, using a more likely than not standard, a series of probability estimates is made for each item to properly measure and record a tax benefit. The tax benefit recorded is generally equal to the highest probable outcome that is more than 50% likely to be realized after full disclosure and resolution of a tax examination. The underlying probabilities are determined based on the best available objective evidence such as recent tax audit outcomes, published guidance, external expert opinion, or by analogy to the outcome of similar issues in the past. There can be no assurance that these estimates will ultimately be realized given continuous changes in tax policy, legislation and audit practice. The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense. |
Pensions | Pensions The Company has U.S. and foreign defined benefit and defined contribution pension plans. The key assumptions in determining the Company’s pension income or expense are the assumed pension liability discount rate and the expected return on plan assets. All unrecognized prior service costs, remaining transition obligations or assets and actuarial gains and losses have been recognized, net of tax effects, as a charge to accumulated other comprehensive income in stockholders’ equity and will be amortized as a component of net periodic pension cost. The Company uses a measurement date of December 31 (its fiscal year end) for its U.S. and foreign defined benefit plans. |
Earnings Per Share | Earnings Per Share The calculation of basic earnings per share is based on the weighted average number of common shares considered outstanding during the periods. The calculation of diluted earnings per share reflects the effect of all potentially dilutive securities (principally outstanding stock options and restricted stock grants). |
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncement | Recently Adopted Accounting Pronouncement In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 8050): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), which provides a single comprehensive accounting model for the acquisition of contract balances under ASC 805. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company early adopted the ASU on January 1, 2022, and the amendments in this ASU were applied on a prospective basis to all periods presented. The adoption of ASU 2021-08 did not impact the Company’s consolidated results of operations, financial position, cash flows or financial statement disclosures. |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Number of Weighted Average Shares | The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows for the years ended December 31: 2022 2021 2020 (In thousands) Weighted average shares: Basic shares 230,208 230,955 229,435 Equity-based compensation plans 1,328 1,858 1,715 Diluted shares 231,536 232,813 231,150 |
Revenues (Tables)
Revenues (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Outstanding Contract Asset and (Liability) Accounts | The outstanding contract asset and liability accounts were as follows: 2022 2021 (In thousands) Contract assets – January 1 $ 95,274 $ 68,971 Contract assets – December 31 119,741 95,274 Change in contract assets – increase 24,467 26,303 Contract liabilities – January 1 328,816 215,093 Contract liabilities – December 31 398,692 328,816 Change in contract liabilities – (increase) (69,876) (113,723) Net change $ (45,409) $ (87,420) |
Revenue from External Customers by Geographic Areas | Information about the Company’s operations in different geographic areas was as follows for the year ended December 31: 2022 EIG EMG Total (In thousands) United States $ 2,171,684 $ 982,579 $ 3,154,263 International (1) : United Kingdom 92,668 117,788 210,456 European Union countries 510,052 420,756 930,808 Asia 1,050,843 266,011 1,316,854 Other foreign countries 404,106 134,043 538,149 Total international 2,057,669 938,598 2,996,267 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 _________________ (1) Includes U.S. export sales of $1,688.7 million. 2021 EIG EMG Total (In thousands) United States $ 1,910,203 $ 890,737 $ 2,800,940 International (1) : United Kingdom 96,206 121,290 217,496 European Union countries 482,426 403,890 886,316 Asia 927,027 254,370 1,181,397 Other foreign countries 347,896 112,469 460,365 Total international 1,853,555 892,019 2,745,574 Consolidated net sales $ 3,763,758 $ 1,782,756 $ 5,546,514 _________________ (1) Includes U.S. export sales of $1,475.6 million. 2020 EIG EMG Total (In thousands) United States $ 1,513,967 $ 816,159 $ 2,330,126 International (1) : United Kingdom 54,158 117,469 171,627 European Union countries 371,884 324,203 696,087 Asia 769,532 189,987 959,519 Other foreign countries 280,387 102,283 382,670 Total international 1,475,961 733,942 2,209,903 Consolidated net sales $ 2,989,928 $ 1,550,101 $ 4,540,029 _________________ |
Revenue from External Customers by Products and Services | The Company’s major products and services in the reportable segments were as follows for the year ended December 31: 2022 EIG EMG Total (In thousands) Process and analytical instrumentation $ 3,061,263 $ — $ 3,061,263 Aerospace and power 1,168,090 549,735 1,717,825 Automation and engineered solutions — 1,371,442 1,371,442 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 2021 EIG EMG Total (In thousands) Process and analytical instrumentation $ 2,627,476 $ — $ 2,627,476 Aerospace and power 1,136,282 506,925 1,643,207 Automation and engineered solutions — 1,275,831 1,275,831 Consolidated net sales $ 3,763,758 $ 1,782,756 $ 5,546,514 2020 EIG EMG Total (In thousands) Process and analytical instrumentation $ 2,199,167 $ — $ 2,199,167 Aerospace and power 790,761 466,343 1,257,104 Automation and engineered solutions — 1,083,758 1,083,758 Consolidated net sales $ 2,989,928 $ 1,550,101 $ 4,540,029 |
Schedule of Disaggregation of Revenue | The Company’s timing of revenue recognition was as follows for the year ended December 31: 2022 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,471,118 $ 1,680,558 $ 5,151,676 Products and services transferred over time 758,235 240,619 998,854 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 2021 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,048,819 $ 1,596,911 $ 4,645,730 Products and services transferred over time 714,939 185,845 900,784 Consolidated net sales $ 3,763,758 $ 1,782,756 $ 5,546,514 2020 EIG EMG Total (In thousands) Products transferred at a point in time $ 2,427,254 $ 1,390,574 $ 3,817,828 Products and services transferred over time 562,674 159,527 722,201 Consolidated net sales $ 2,989,928 $ 1,550,101 $ 4,540,029 |
Schedule of Product Warranty Liability | Changes in the accrued product warranty obligation were as follows: 2022 2021 2020 (In thousands) Balance at the beginning of the year $ 27,478 $ 27,839 $ 27,611 Accruals for warranties issued during the year 11,414 11,518 12,000 Settlements made during the year (11,835) (13,669) (14,602) Warranty accruals related to acquired businesses and other during the year (570) 1,790 2,830 Balance at the end of the year $ 26,487 $ 27,478 $ 27,839 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Assets Measured on Recurring Basis | The following tables provide the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31: 2022 Total Level 1 Level 2 Level 3 (In thousands) Mutual fund investments $ 9,856 $ 9,856 $ — $ — Foreign currency forward contracts 3,032 — 3,032 — 2021 Total Level 1 Level 2 Level 3 (In thousands) Mutual fund investments $ 10,703 $ 10,703 $ — $ — |
Acquisitions and Divestiture (T
Acquisitions and Divestiture (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Business Combinations [Abstract] | |
Allocation of Aggregate Purchase Price of Acquired Net Assets | The following table represents the allocation of the purchase price for the net assets of the 2022 acquisitions based on the estimated fair values at acquisition (in millions): Property, plant and equipment $ 11.8 Goodwill 197.8 Other intangible assets 213.3 Deferred income taxes (23.5) Net working capital and other (1) 30.3 Total cash paid $ 429.7 ______________________ (1) Includes $18.4 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal. |
Goodwill and Other Intangible_2
Goodwill and Other Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Changes in Carrying Amounts of Goodwill by Segment | The changes in the carrying amounts of goodwill by segment were as follows: EIG EMG Total (In millions) Balance at December 31, 2020 $ 3,050.3 $ 1,174.6 $ 4,224.9 Goodwill acquired 1,037.9 5.9 1,043.8 Purchase price allocation adjustments and other 1.9 — 1.9 Foreign currency translation adjustments (16.3) (15.6) (31.9) Balance at December 31, 2021 4,073.8 1,164.9 5,238.7 Goodwill acquired 197.8 — 197.8 Purchase price allocation adjustments and other 1.8 — 1.8 Foreign currency translation adjustments (37.3) (28.4) (65.7) Balance at December 31, 2022 $ 4,236.1 $ 1,136.5 $ 5,372.6 |
Other Intangible Assets | Other intangible assets were as follows at December 31: 2022 2021 (In thousands) Definite-lived intangible assets (subject to amortization): Patents $ 46,418 $ 48,071 Purchased technology 722,277 677,896 Customer lists 3,023,762 2,930,120 3,792,457 3,656,087 Accumulated amortization: Patents (37,215) (37,713) Purchased technology (269,155) (235,989) Customer lists (1,033,658) (888,092) (1,340,028) (1,161,794) Net intangible assets subject to amortization 2,452,429 2,494,293 Indefinite-lived intangible assets (not subject to amortization): Trademarks and trade names 889,656 874,336 $ 3,342,085 $ 3,368,629 |
Other Consolidated Balance Sh_2
Other Consolidated Balance Sheet Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Other Consolidated Balance Sheet Information | December 31, 2022 2021 (In thousands) INVENTORIES, NET Finished goods and parts $ 130,989 $ 89,985 Work in process 138,043 122,356 Raw materials and purchased parts 775,252 556,834 $ 1,044,284 $ 769,175 PROPERTY, PLANT AND EQUIPMENT, NET Land $ 55,915 $ 41,709 Buildings 365,679 343,996 Machinery and equipment 1,199,600 1,149,316 1,621,194 1,535,021 Less: Accumulated depreciation (985,553) (917,883) $ 635,641 $ 617,138 ACCRUED LIABILITIES AND OTHER Employee compensation and benefits $ 213,478 $ 205,994 Product warranty obligation 26,487 27,478 Realignment 34,394 30,476 Short term lease liability 46,366 47,353 Other 114,419 132,036 $ 435,144 $ 443,337 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Components of Income before Income Taxes and Details of Provision for Income Taxes | The components of income before income taxes and the details of the provision for income taxes were as follows for the years ended December 31: 2022 2021 2020 (In thousands) Income before income taxes: Domestic $ 893,478 $ 958,206 $ 810,844 Foreign 535,214 264,964 271,465 Total $ 1,428,692 $ 1,223,170 $ 1,082,309 Provision for income taxes: Current: Federal $ 183,619 $ 99,706 $ 126,427 Foreign 119,148 146,890 61,672 State 34,201 16,282 19,932 Total current 336,968 262,878 208,031 Deferred: Federal (37,810) 23,538 (1,254) Foreign (20,818) (56,572) (4,072) State (9,190) 3,273 7,165 Total deferred (67,818) (29,761) 1,839 Total provision $ 269,150 $ 233,117 $ 209,870 |
Components of Deferred Tax (Asset) Liability | Significant components of the deferred tax (asset) liability were as follows at December 31: 2022 2021 (In thousands) Non-current deferred tax (asset) liability: Differences in basis of property and accelerated depreciation (1) $ 43,594 $ 44,199 Reserves not currently deductible (131,958) (118,578) Pensions 66,558 63,329 Differences in basis of intangible assets and accelerated amortization 726,525 768,542 Net operating loss carryforwards (54,318) (44,164) Share-based compensation (13,279) (12,728) Foreign Tax Credit Carryforwards (2,317) (2,291) Unremitted earnings 12,429 11,361 Other (13,448) (28,343) 633,786 681,327 Less: Valuation allowance 9,613 11,349 643,399 692,676 Portion included in non-current assets 50,868 26,999 Gross non-current deferred tax liability $ 694,267 $ 719,675 ______________________ (1) Presented net of deferred tax assets of approximately $34.1 million and $33.3 million at December 31, 2022 and 2021, respectively, resulting from lease obligations. |
Reconciliation of Effective Tax Rate to U.S. Federal Statutory Rate | The Company’s effective tax rate reconciles to the U.S. Federal statutory rate as follows for the years ended December 31: 2022 2021 2020 U.S. Federal statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal income tax benefit 1.6 1.5 2.3 Foreign operations, net (1.0) (0.4) (1.4) U.S. Benefits for Manufacturing, Export and credits (2.9) (2.6) (1.9) Uncertain Tax Items 1.0 (0.1) (1.3) Stock compensation (0.9) (1.7) (1.0) U.S. Tax on Foreign Earnings 0.5 3.9 2.2 U.S. General Basket FTC (0.1) (2.9) (0.1) Other (0.4) 0.3 (0.5) Consolidated effective tax rate 18.8 % 19.1 % 19.4 % |
Reconciliation of Liability for Uncertain Tax Positions | The following is a reconciliation of the liability for uncertain tax positions at December 31: 2022 2021 2020 (In millions) Balance at the beginning of the year $ 147.0 $ 100.7 $ 109.1 Additions for tax positions related to the current year 29.3 41.4 15.6 Additions for tax positions of prior years 2.1 34.9 6.2 Reductions for tax positions of prior years (1.0) (1.5) (0.3) Reductions related to settlements with taxing authorities (0.2) (0.1) (0.5) Reductions due to statute expirations (2.5) (28.4) (29.4) Balance at the end of the year $ 174.7 $ 147.0 $ 100.7 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Long-term Debt | Long-term debt, net consisted of the following at December 31: 2022 2021 (In thousands) U.S. dollar 3.73% senior notes due September 2024 $ 300,000 $ 300,000 U.S. dollar 3.91% senior notes due June 2025 50,000 50,000 U.S. dollar 3.96% senior notes due August 2025 100,000 100,000 U.S. dollar 4.18% senior notes due December 2025 275,000 275,000 U.S. dollar 3.83% senior notes due September 2026 100,000 100,000 U.S. dollar 4.32% senior notes due December 2027 250,000 250,000 U.S. dollar 4.37% senior notes due December 2028 50,000 50,000 U.S. dollar 3.98% senior notes due September 2029 100,000 100,000 U.S. dollar 4.45% senior notes due August 2035 50,000 50,000 British pound 2.59% senior note due November 2028 181,157 203,046 British pound 2.70% senior note due November 2031 90,579 101,510 Euro 1.34% senior notes due October 2026 320,808 341,284 Euro 1.71% senior notes due December 2027 80,205 85,323 Euro 1.53% senior notes due October 2028 213,894 227,541 Revolving credit facility borrowings 219,000 314,480 Other, principally foreign 11,759 1,976 Less: Debt issuance costs (7,395) (5,919) Total debt, net 2,385,007 2,544,241 Less: Current portion, net (226,079) (315,093) Total long-term debt, net $ 2,158,928 $ 2,229,148 |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Total Share-Based Compensation Expense | Total share-based compensation expense was as follows for the years ended December 31: 2022 2021 2020 (In thousands) Stock option expense $ 13,021 $ 12,733 $ 13,695 Restricted stock expense 20,115 21,393 17,997 PRSU expense 14,239 11,977 9,873 Total pre-tax expense $ 47,375 $ 46,103 $ 41,565 |
Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted | The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the years indicated: 2022 2021 2020 Expected volatility 24.5 % 24.2 % 22.2 % Expected term (years) 5.0 5.0 5.0 Risk-free interest rate 2.33 % 0.85 % 0.52 % Expected dividend yield 0.65 % 0.66 % 1.14 % Black-Scholes-Merton fair value per stock option granted $ 32.54 $ 25.63 $ 11.01 |
Summary of Stock Option Activity and Related Information | The following is a summary of the Company’s stock option activity and related information for the year ended December 31, 2022: Shares Weighted Weighted Aggregate (In thousands) (Years) (In millions) Outstanding at the beginning of the year 3,352 $ 76.08 Granted 608 134.69 Exercised (788) 63.75 Forfeited (107) 108.79 Expired (5) 101.38 Outstanding at the end of the year 3,060 $ 79.46 6.5 $ 153.0 Exercisable at the end of the year 1,944 $ 75.00 5.4 $ 125.8 |
Summary of Nonvested Stock Option Activity and Related Information | The following is a summary of the Company’s non-vested stock option activity and related information for the year ended December 31, 2022: Shares Weighted (In thousands) Non-vested stock options outstanding at the beginning of the year 1,292 $ 18.41 Granted 608 32.54 Vested (677) 16.78 Forfeited (107) 23.86 Non-vested stock options outstanding at the end of the year 1,116 $ 26.57 |
Summary of Nonvested Restricted Stock Activity and Related Information | The following is a summary of the Company’s non-vested restricted stock activity and related information for the year ended December 31, 2022: Shares Weighted (In thousands) Non-vested restricted stock outstanding at the beginning of the year 413 $ 96.07 Granted 184 134.52 Vested (195) 90.78 Forfeited (46) 109.08 Non-vested restricted stock outstanding at the end of the year 356 $ 117.18 The following is a summary of the Company’s non-vested performance restricted stock activity and related information for the year ended December 31, 2022: Shares Weighted (In thousands) Non-vested performance restricted stock outstanding at the beginning of the year 289 $ 85.29 Granted 87 134.69 Performance assumption change 1 66 81.76 Vested (161) 81.76 Forfeited (6) 98.07 Non-vested performance restricted stock outstanding at the end of the year 275 $ 101.98 _________________________________________ 1 Reflects the number of PRSUs above target levels based on performance metrics. |
Retirement Plans and Other Po_2
Retirement Plans and Other Postretirement Benefits (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Net Projected Benefit Obligation and Fair Value of Plan Assets for Funded and Unfunded Defined Benefit Plans | The following tables set forth the changes in net projected benefit obligation and the fair value of plan assets for the funded and unfunded defined benefit plans for the years ended December 31: U.S. Defined Benefit Pension Plans: 2022 2021 (In thousands) Change in projected benefit obligation: Net projected benefit obligation at the beginning of the year $ 504,773 $ 532,357 Service cost 2,067 2,767 Interest cost 14,889 14,074 Actuarial (gains) losses (106,159) (12,593) Gross benefits paid (32,090) (31,832) Acquisition (337) — Net projected benefit obligation at the end of the year $ 383,143 $ 504,773 Change in plan assets: Fair value of plan assets at the beginning of the year $ 701,627 $ 662,298 Actual return on plan assets (101,381) 70,540 Employer contributions 1,230 621 Gross benefits paid (32,090) (31,832) Acquisition (337) — Fair value of plan assets at the end of the year $ 569,049 $ 701,627 Foreign Defined Benefit Pension Plans: 2022 2021 (In thousands) Change in projected benefit obligation: Net projected benefit obligation at the beginning of the year $ 332,422 $ 351,584 Service cost 2,852 4,218 Interest cost 5,235 4,458 Foreign currency translation adjustments (31,367) (6,580) Employee contributions — 76 Actuarial (gains) losses (100,201) (10,199) Expenses paid from assets (686) (1,121) Gross benefits paid (9,409) (10,426) Settlements (102) — Curtailments — 412 Net projected benefit obligation at the end of the year $ 198,744 $ 332,422 Change in plan assets: Fair value of plan assets at the beginning of the year $ 266,288 $ 250,735 Actual return on plan assets (77,643) 20,184 Employer contributions 7,729 9,656 Employee contributions — 76 Foreign currency translation adjustments (26,585) (2,816) Expenses paid from assets (686) (1,121) Settlements (102) — Gross benefits paid (9,409) (10,426) Fair value of plan assets at the end of the year $ 159,592 $ 266,288 |
Accumulated Benefit Obligation ("ABO") | The accumulated benefit obligation consisted of the following at December 31: U.S. Defined Benefit Pension Plans: 2022 2021 (In thousands) Funded plans $ 374,979 $ 492,957 Unfunded plans 2,869 3,913 Total $ 377,848 $ 496,870 Foreign Defined Benefit Pension Plans: 2022 2021 (In thousands) Funded plans $ 167,495 $ 284,013 Unfunded plans 30,924 47,761 Total $ 198,419 $ 331,774 |
Weighted Average Assumptions Used to Determine Benefit Obligations | Weighted average assumptions used to determine benefit obligations at December 31: 2022 2021 U.S. Defined Benefit Pension Plans: Discount rate 5.65 % 3.02 % Rate of compensation increase (where applicable) 3.75 % 3.75 % Foreign Defined Benefit Pension Plans: Discount rate 4.73 % 1.78 % Rate of compensation increase (where applicable) 2.50 % 2.50 % The following weighted average assumptions were used to determine the above net periodic pension benefit income for the years ended December 31: 2022 2021 2020 U.S. Defined Benefit Pension Plans: Discount rate 3.02 % 2.69 % 3.45 % Expected return on plan assets 6.75 % 6.75 % 7.00 % Rate of compensation increase (where applicable) 3.75 % 3.75 % 3.75 % Foreign Defined Benefit Pension Plans: Discount rate 1.78 % 1.27 % 1.83 % Expected return on plan assets 5.85 % 5.47 % 5.97 % Rate of compensation increase (where applicable) 2.50 % 2.50 % 2.50 % |
Fair Value of Plan Assets | The following is a summary of the fair value of plan assets for U.S. plans at December 31: 2022 2021 Asset Class Total Level 1 Level 2 Total Level 1 Level 2 (In thousands) Corporate debt instruments $ 6,192 $ — $ 6,192 $ 4,053 $ — $ 4,053 Corporate debt instruments – Preferred 13,425 — 13,425 11,265 — 11,265 Corporate stocks – Common 53,629 53,629 — 67,975 67,975 — Municipal bonds 711 — 711 676 — 676 Registered investment companies 155,541 155,541 — 150,535 150,535 — U.S. Government securities 1,253 — 1,253 663 — 663 Total investments 230,751 209,170 21,581 235,167 218,510 16,657 Investments measured at net asset value 338,298 — — 466,460 — — Total investments $ 569,049 $ 209,170 $ 21,581 $ 701,627 $ 218,510 $ 16,657 The following is a summary of the fair value of plan assets for foreign defined benefit pension plans at December 31: 2022 2021 Asset Class Total Level 3 Total Level 3 (In thousands) Life insurance $ 13,043 $ 13,043 $ 18,806 $ 18,806 Total investments 13,043 13,043 18,806 18,806 Investments measured at net asset value 146,549 — 247,482 — Total investments $ 159,592 $ 13,043 $ 266,288 $ 18,806 |
Summary of Changes in Fair Value of U.S. Plans' Investments Using Significant Unobservable Inputs | The following is a summary of the changes in the fair value of the foreign plans’ level 3 investments (fair value determined using significant unobservable inputs): Life Insurance (In thousands) Balance, December 31, 2020 $ 20,908 Actual return on assets: Unrealized losses relating to instruments still held at the end of the year $ (2,102) Realized gains (losses) relating to assets sold during the year $ — Purchases, sales, issuances and settlements, net $ — Balance, December 31, 2021 $ 18,806 Actual return on assets: Unrealized gains (losses) relating to instruments still held at the end of the year $ (5,763) Realized gains (losses) relating to assets sold during the year $ — Purchases, sales, issuances and settlements, net $ — Balance, December 31, 2022 $ 13,043 |
Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets | The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with a projected benefit obligation in excess of plan assets and pension plans with an accumulated benefit obligation in excess of plan assets were as follows at December 31: U.S. Defined Benefit Pension Plans: Projected Benefit Accumulated Benefit 2022 2021 2022 2021 (In thousands) Benefit obligation $ 4,043 $ 6,234 $ 4,043 $ 6,234 Fair value of plan assets 707 1,239 707 1,239 Foreign Defined Benefit Pension Plans: Projected Benefit Accumulated Benefit 2022 2021 2022 2021 (In thousands) Benefit obligation $ 162,105 $ 272,245 $ 161,780 $ 271,596 Fair value of plan assets 120,056 200,862 120,056 200,862 |
Funded Status of Plan and Amounts Recognized in Balance Sheet | The following table provides the amounts recognized in the consolidated balance sheet at December 31: 2022 2021 (In thousands) Funded status asset (liability): Fair value of plan assets $ 728,641 $ 967,915 Projected benefit obligation (581,887) (837,195) Funded status at the end of the year $ 146,754 $ 130,720 Amounts recognized in the consolidated balance sheet consisted of: Non-current asset for pension benefits (other assets) $ 192,140 $ 207,099 Current liabilities for pension benefits (2,700) (2,133) Non-current liability for pension benefits (42,686) (74,246) Net amount recognized at the end of the year $ 146,754 $ 130,720 |
Amounts Recognized in Accumulated Other Comprehensive Income, Net of Taxes | The following table provides the amounts recognized in accumulated other comprehensive income, net of taxes, at December 31: Net amounts recognized: 2022 2021 (In thousands) Net actuarial loss $ 205,193 $ 193,220 Prior service costs 1,625 1,855 Transition asset 3 4 Total recognized $ 206,821 $ 195,079 |
Components of Net Periodic Pension Benefit Expense (Income) | The following table provides the components of net periodic pension benefit expense (income) for the years ended December 31: 2022 2021 2020 (In thousands) Defined benefit plans: Service cost $ 4,919 $ 6,985 $ 7,261 Interest cost 20,124 18,532 22,611 Expected return on plan assets (60,104) (56,752) (54,629) Curtailment — 3,151 — Settlement (58) — — Amortization of: Net actuarial loss 8,531 16,353 15,479 Prior service costs 100 456 486 Transition asset 1 1 1 Total net periodic benefit income (26,487) (11,274) (8,791) Other plans: Defined contribution plans 39,326 31,149 30,829 Foreign plans and other 8,373 8,454 7,902 Total other plans 47,699 39,603 38,731 Total net pension expense $ 21,212 $ 28,329 $ 29,940 |
Leases and Other Commitments (T
Leases and Other Commitments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Components of Lease Expense | The components of lease expense were as follows: 2022 2021 2020 (In thousands) Operating lease cost $ 59,296 $ 61,680 $ 44,498 Variable lease cost 11,096 7,724 4,526 Total lease cost $ 70,392 $ 69,404 $ 49,024 |
Supplemental Balance Sheet Information Related to Leases | Supplemental balance sheet information related to leases was as follows: December 31, 2022 2021 (In thousands) Right of use assets, net $ 170,295 $ 169,924 Lease liabilities included in Accrued liabilities and other 46,366 47,353 Lease liabilities included in Other long-term liabilities 129,227 129,101 Total lease liabilities $ 175,593 $ 176,454 |
Supplemental Cash Flow Information Related to Leases | Supplemental cash flow information and other information related to leases was as follows for the year ended December 31: 2022 2021 (In thousands) Cash used in operations for operating leases $ 54,724 $ 55,657 Right-of-use assets obtained in exchange for new operating liabilities $ 59,802 $ 64,653 Weighted-average remaining lease terms – operating leases (years) 5.07 5.36 Weighted-average discount rate – operating leases 3.32 % 2.91 % |
Maturities of Lease Liabilities | Maturities of lease liabilities as of December 31, 2022 were as follows: Lease Liability Maturity Analysis Operating Leases (In thousands) 2023 $ 51,740 2024 41,047 2025 31,338 2026 23,770 2027 15,467 Thereafter 29,523 Total lease payments 192,885 Less: imputed interest 17,292 $ 175,593 |
Reportable Segments and Geogr_2
Reportable Segments and Geographic Areas Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Reportable Segment Financial Information | 2022 2021 2020 (In thousands) Operating income and income before income taxes: Segment operating income: Electronic Instruments $ 1,089,729 $ 958,183 $ 770,620 Electromechanical 503,593 437,378 324,962 Total segment operating income 1,593,322 1,395,561 1,095,582 Corporate administrative expenses (92,630) (86,891) (67,698) Consolidated operating income 1,500,692 1,308,670 1,027,884 Interest and other income (expenses), net (72,000) (85,500) 54,425 Consolidated income before income taxes $ 1,428,692 $ 1,223,170 $ 1,082,309 Assets: Electronic Instruments $ 9,430,797 $ 8,672,711 Electromechanical 2,617,685 2,638,773 Total segment assets 12,048,482 11,311,484 Corporate 382,638 586,703 Consolidated assets $ 12,431,120 $ 11,898,187 2022 2021 2020 (In thousands) Additions to property, plant and equipment (1) : Electronic Instruments $ 93,505 $ 168,267 $ 48,638 Electromechanical 38,186 34,586 26,381 Total segment additions to property, plant and equipment 131,691 202,853 75,019 Corporate 19,757 10,417 1,007 Consolidated additions to property, plant and equipment $ 151,448 $ 213,270 $ 76,026 Depreciation and amortization: Electronic Instruments $ 238,436 $ 210,118 $ 174,494 Electromechanical 77,896 79,497 78,297 Total segment depreciation and amortization 316,332 289,615 252,791 Corporate 3,095 2,497 2,484 Consolidated depreciation and amortization $ 319,427 $ 292,112 $ 255,275 ___________________ (1) Includes $12.4 million in 2022, $102.6 million in 2021 and $1.8 million in 2020 from acquired businesses. |
Information about Company's Operations in Different Geographic Areas | Information about the Company’s operations in different geographic areas for the years ended December 31, 2022 and 2021 is shown below. 2022 2021 (In thousands) Long-lived assets from continuing operations (excluding intangible assets): United States $ 412,577 $ 416,323 International (1) : United Kingdom 71,462 74,525 European Union countries 89,993 87,117 Asia 11,479 11,971 Other foreign countries 50,130 27,202 Total international 223,064 200,815 Total consolidated $ 635,641 $ 617,138 _________________ (1) Represents long-lived assets of foreign-based operations only. |
Significant Accounting Polici_4
Significant Accounting Policies - Additional Information (Detail) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 USD ($) operation | Dec. 31, 2021 USD ($) shares | Dec. 31, 2020 USD ($) shares | |
Significant Accounting Policies [Line Items] | |||
Bad debt expense | $ 3,700 | $ 1,200 | $ 3,600 |
Allowance for estimated credit losses | $ 14,100 | 11,200 | |
Percentage of FIFO method of inventory in total inventory | 90% | ||
Percentage of LIFO method of inventory in total inventory | 10% | ||
Excess of the FIFO value over the LIFO value | $ 40,300 | 29,800 | |
Depreciation expense | $ 113,700 | 108,500 | 101,300 |
Number of operating groups | operation | 2 | ||
Research and development costs | $ 198,800 | 194,200 | 158,900 |
Shipping and handling costs | 4,005,261 | $ 3,633,900 | $ 2,996,515 |
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | shares | 0 | 0 | |
Shipping and Handling | |||
Significant Accounting Policies [Line Items] | |||
Shipping and handling costs | $ 103,700 | $ 86,100 | $ 56,800 |
Patents and Technology | |||
Significant Accounting Policies [Line Items] | |||
Weighted average life | 14 years | ||
Patents and Technology | Minimum | |||
Significant Accounting Policies [Line Items] | |||
Useful life, maximum | 9 years | ||
Patents and Technology | Maximum | |||
Significant Accounting Policies [Line Items] | |||
Useful life, maximum | 20 years | ||
Customer Relationship | |||
Significant Accounting Policies [Line Items] | |||
Weighted average life | 19 years | ||
Customer Relationship | Minimum | |||
Significant Accounting Policies [Line Items] | |||
Useful life, maximum | 10 years | ||
Customer Relationship | Maximum | |||
Significant Accounting Policies [Line Items] | |||
Useful life, maximum | 20 years | ||
Machinery and Equipment | Minimum | |||
Significant Accounting Policies [Line Items] | |||
Range of lives for depreciable assets, maximum | 3 years | ||
Machinery and Equipment | Maximum | |||
Significant Accounting Policies [Line Items] | |||
Range of lives for depreciable assets, maximum | 10 years | ||
Leasehold Improvements | Minimum | |||
Significant Accounting Policies [Line Items] | |||
Range of lives for depreciable assets, maximum | 5 years | ||
Leasehold Improvements | Maximum | |||
Significant Accounting Policies [Line Items] | |||
Range of lives for depreciable assets, maximum | 27 years | ||
Building | Minimum | |||
Significant Accounting Policies [Line Items] | |||
Range of lives for depreciable assets, maximum | 25 years | ||
Building | Maximum | |||
Significant Accounting Policies [Line Items] | |||
Range of lives for depreciable assets, maximum | 50 years |
Significant Accounting Polici_5
Significant Accounting Policies - Number of Weighted Average Shares (Detail) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Weighted average shares: | |||
Basic shares | 230,208 | 230,955 | 229,435 |
Equity-based compensation plans (in shares) | 1,328 | 1,858 | 1,715 |
Diluted shares | 231,536 | 232,813 | 231,150 |
Revenues - Outstanding Contract
Revenues - Outstanding Contract Asset and (Liability) Accounts (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |||
Contract assets | $ 119,741 | $ 95,274 | $ 68,971 |
Change in contract assets – increase | 24,467 | 26,303 | |
Contract liabilities | 398,692 | 328,816 | $ 215,093 |
Change in contract liabilities – (increase) | (69,876) | (113,723) | |
Net change | $ (45,409) | $ (87,420) |
Revenues - Additional Informati
Revenues - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue recognized from contract liabilities | $ 272 | $ 184 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | ||
Revenue, remaining performance obligation | $ 342.5 | |
Expected timing of satisfaction, period | 1 year | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | ||
Revenue, remaining performance obligation | $ 526 | |
Expected timing of satisfaction, period | 1 year | |
Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | ||
Expected timing of satisfaction, period | 2 years | |
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | ||
Expected timing of satisfaction, period | 3 years | |
Other Noncurrent Liabilities | ||
Customer advanced payments | $ 41 | $ 30.1 |
Revenues - Information about Op
Revenues - Information about Operations in Different Geographic Areas (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Segment Reporting Information [Line Items] | |||
Net sales | $ 6,150,530 | $ 5,546,514 | $ 4,540,029 |
United States | |||
Segment Reporting Information [Line Items] | |||
Net sales | 3,154,263 | 2,800,940 | 2,330,126 |
United Kingdom | |||
Segment Reporting Information [Line Items] | |||
Net sales | 210,456 | 217,496 | 171,627 |
European Union countries | |||
Segment Reporting Information [Line Items] | |||
Net sales | 930,808 | 886,316 | 696,087 |
Asia | |||
Segment Reporting Information [Line Items] | |||
Net sales | 1,316,854 | 1,181,397 | 959,519 |
Other foreign countries | |||
Segment Reporting Information [Line Items] | |||
Net sales | 538,149 | 460,365 | 382,670 |
International | |||
Segment Reporting Information [Line Items] | |||
Net sales | 2,996,267 | 2,745,574 | 2,209,903 |
Non-US | |||
Segment Reporting Information [Line Items] | |||
Net sales | 1,688,700 | 1,475,600 | 1,196,400 |
EIG | |||
Segment Reporting Information [Line Items] | |||
Net sales | 4,229,353 | 3,763,758 | 2,989,928 |
EIG | United States | |||
Segment Reporting Information [Line Items] | |||
Net sales | 2,171,684 | 1,910,203 | 1,513,967 |
EIG | United Kingdom | |||
Segment Reporting Information [Line Items] | |||
Net sales | 92,668 | 96,206 | 54,158 |
EIG | European Union countries | |||
Segment Reporting Information [Line Items] | |||
Net sales | 510,052 | 482,426 | 371,884 |
EIG | Asia | |||
Segment Reporting Information [Line Items] | |||
Net sales | 1,050,843 | 927,027 | 769,532 |
EIG | Other foreign countries | |||
Segment Reporting Information [Line Items] | |||
Net sales | 404,106 | 347,896 | 280,387 |
EIG | International | |||
Segment Reporting Information [Line Items] | |||
Net sales | 2,057,669 | 1,853,555 | 1,475,961 |
EMG | |||
Segment Reporting Information [Line Items] | |||
Net sales | 1,921,177 | 1,782,756 | 1,550,101 |
EMG | United States | |||
Segment Reporting Information [Line Items] | |||
Net sales | 982,579 | 890,737 | 816,159 |
EMG | United Kingdom | |||
Segment Reporting Information [Line Items] | |||
Net sales | 117,788 | 121,290 | 117,469 |
EMG | European Union countries | |||
Segment Reporting Information [Line Items] | |||
Net sales | 420,756 | 403,890 | 324,203 |
EMG | Asia | |||
Segment Reporting Information [Line Items] | |||
Net sales | 266,011 | 254,370 | 189,987 |
EMG | Other foreign countries | |||
Segment Reporting Information [Line Items] | |||
Net sales | 134,043 | 112,469 | 102,283 |
EMG | International | |||
Segment Reporting Information [Line Items] | |||
Net sales | $ 938,598 | $ 892,019 | $ 733,942 |
Revenues - Major Products and S
Revenues - Major Products and Services in Reportable Segments (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 6,150,530 | $ 5,546,514 | $ 4,540,029 |
Process and analytical instrumentation | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 3,061,263 | 2,627,476 | 2,199,167 |
Aerospace and power | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,717,825 | 1,643,207 | 1,257,104 |
Automation and engineered solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,371,442 | 1,275,831 | 1,083,758 |
EIG | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 4,229,353 | 3,763,758 | 2,989,928 |
EIG | Process and analytical instrumentation | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 3,061,263 | 2,627,476 | 2,199,167 |
EIG | Aerospace and power | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,168,090 | 1,136,282 | 790,761 |
EIG | Automation and engineered solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
EMG | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,921,177 | 1,782,756 | 1,550,101 |
EMG | Process and analytical instrumentation | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
EMG | Aerospace and power | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 549,735 | 506,925 | 466,343 |
EMG | Automation and engineered solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 1,371,442 | $ 1,275,831 | $ 1,083,758 |
Revenues - Timing of Revenue Re
Revenues - Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 6,150,530 | $ 5,546,514 | $ 4,540,029 |
Products transferred at a point in time | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 5,151,676 | 4,645,730 | 3,817,828 |
Products and services transferred over time | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 998,854 | 900,784 | 722,201 |
EIG | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 4,229,353 | 3,763,758 | 2,989,928 |
EIG | Products transferred at a point in time | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 3,471,118 | 3,048,819 | 2,427,254 |
EIG | Products and services transferred over time | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 758,235 | 714,939 | 562,674 |
EMG | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,921,177 | 1,782,756 | 1,550,101 |
EMG | Products transferred at a point in time | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,680,558 | 1,596,911 | 1,390,574 |
EMG | Products and services transferred over time | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 240,619 | $ 185,845 | $ 159,527 |
Revenues - Changes in Accrued P
Revenues - Changes in Accrued Product Warranty Obligation (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Movement in Standard Product Warranty Accrual [Roll Forward] | |||
Balance at the beginning of the year | $ 27,478 | $ 27,839 | $ 27,611 |
Accruals for warranties issued during the year | 11,414 | 11,518 | 12,000 |
Settlements made during the year | (11,835) | (13,669) | (14,602) |
Warranty accruals related to acquired businesses and other during the year | (570) | 1,790 | 2,830 |
Balance at the end of the year | $ 26,487 | $ 27,478 | $ 27,839 |
Fair Value Measurements - Fair
Fair Value Measurements - Fair Value of Assets Measured on Recurring Basis (Detail) - Recurring - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Mutual fund investments | $ 9,856 | $ 10,703 |
Foreign currency forward contracts | 3,032 | |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Mutual fund investments | 9,856 | 10,703 |
Foreign currency forward contracts | 0 | |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Mutual fund investments | 0 | 0 |
Foreign currency forward contracts | 3,032 | |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Mutual fund investments | 0 | $ 0 |
Foreign currency forward contracts | $ 0 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Detail) € in Millions, $ in Millions | Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Dec. 31, 2022 CAD ($) | Dec. 31, 2021 USD ($) |
Recurring | ||||
Derivative [Line Items] | ||||
Foreign currency forward contracts | $ 3,032,000 | |||
Level 3 | Recurring | ||||
Derivative [Line Items] | ||||
Foreign currency forward contracts | 0 | |||
Long-term debt, fair value | (2,010,900,000) | $ (2,378,900,000) | ||
Reported Value Measurement | ||||
Derivative [Line Items] | ||||
Long-term debt, fair value | (2,161,600,000) | (2,233,700,000) | ||
Foreign Exchange Forward | United States of America, Dollars | ||||
Derivative [Line Items] | ||||
Derivative, notional amount | $ 0 | $ 0 | ||
Euro Forward Contract | ||||
Derivative [Line Items] | ||||
Foreign currency forward contracts | € | € 40 | |||
Canadian Dollar Forward Contract | ||||
Derivative [Line Items] | ||||
Foreign currency forward contracts | $ 26.5 |
Hedging Activities - Additional
Hedging Activities - Additional Information (Detail) - Foreign Exchange Contract - Designated as Hedging Instrument - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Derivative [Line Items] | ||
Percentage of effectiveness on net investment hedges | 100% | |
Currency remeasurement gains (losses) | $ 69.5 | $ 51.7 |
British-Pound-Denominated Loans | ||
Derivative [Line Items] | ||
Hedge against net investment in foreign subsidiaries | 271.7 | 304.6 |
Euro Loan | ||
Derivative [Line Items] | ||
Hedge against net investment in foreign subsidiaries | $ 572.1 | $ 654.1 |
Acquisitions and Divestiture -
Acquisitions and Divestiture - Additional Information (Detail) - USD ($) $ in Thousands | 1 Months Ended | 2 Months Ended | 12 Months Ended | |||
Mar. 31, 2020 | Jan. 31, 2020 | Oct. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Acquisition [Line Items] | ||||||
Purchases of businesses, net of cash acquired | $ 429,714 | $ 1,959,218 | $ 116,509 | |||
Proceeds from sale of business/investment | 3,734 | 12,000 | 245,311 | |||
Gain on sale of business/investment | $ 141,000 | 3,584 | 6,349 | $ 141,020 | ||
Income tax expense relating to sale of business | 31,400 | |||||
2022 Consolidated Acquisition | ||||||
Business Acquisition [Line Items] | ||||||
Purchases of businesses, net of cash acquired | $ 429,700 | 429,700 | ||||
Business acquisition, goodwill, expected tax deductible amount | 71,400 | |||||
Other intangible assets | 213,300 | |||||
Finite-lived intangible assets acquired | 176,100 | |||||
Future amortization expense, year four | 11,100 | |||||
Future amortization expense, year one | 11,100 | |||||
Future amortization expense, year two | 11,100 | |||||
Future amortization expense, year three | 11,100 | |||||
Future amortization expense, year five | 11,100 | |||||
2022 Consolidated Acquisition | Trade Names | ||||||
Business Acquisition [Line Items] | ||||||
Indefinite-lived intangible trade names acquired | 37,200 | |||||
2022 Consolidated Acquisition | Customer Relationship | ||||||
Business Acquisition [Line Items] | ||||||
Finite-lived intangible assets acquired | $ 120,100 | |||||
Amortization period for finite-lived intangible asset | 19 years | |||||
2022 Consolidated Acquisition | Purchased technology | ||||||
Business Acquisition [Line Items] | ||||||
Finite-lived intangible assets acquired | $ 56,000 | |||||
Amortization period for finite-lived intangible asset | 5 years | |||||
2022 Consolidated Acquisition | Purchased technology | Minimum | ||||||
Business Acquisition [Line Items] | ||||||
Amortization period for finite-lived intangible asset | 11 years | |||||
2022 Consolidated Acquisition | Purchased technology | Maximum | ||||||
Business Acquisition [Line Items] | ||||||
Amortization period for finite-lived intangible asset | 15 years | |||||
2021 Consolidated Acquisition | ||||||
Business Acquisition [Line Items] | ||||||
Purchases of businesses, net of cash acquired | $ 1,959,200 | |||||
IntelliPower | ||||||
Business Acquisition [Line Items] | ||||||
Purchases of businesses, net of cash acquired | $ 116,500 | |||||
Kymera International | Reading Alloys | ||||||
Business Acquisition [Line Items] | ||||||
Proceeds from sale of business/investment | $ 245,300 |
Acquisitions and Divestiture _2
Acquisitions and Divestiture - Allocation of Aggregate Purchase Price of Acquired Net Assets (Detail) - USD ($) $ in Thousands | 2 Months Ended | 12 Months Ended | ||
Oct. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Acquisition [Line Items] | ||||
Goodwill | $ 5,372,562 | $ 5,238,726 | $ 4,224,900 | |
Purchases of businesses, net of cash acquired | 429,714 | $ 1,959,218 | $ 116,509 | |
2022 Consolidated Acquisition | ||||
Business Acquisition [Line Items] | ||||
Property, plant and equipment | 11,800 | |||
Goodwill | 197,800 | |||
Other intangible assets | 213,300 | |||
Deferred income taxes | (23,500) | |||
Net working capital and other | 30,300 | |||
Purchases of businesses, net of cash acquired | $ 429,700 | 429,700 | ||
2022 Consolidated Acquisition | Pacific Design Technologies Inc | ||||
Business Acquisition [Line Items] | ||||
Accounts receivable included in purchase price | $ 18,400 |
Goodwill and Other Intangible_3
Goodwill and Other Intangible Assets - Changes in Carrying Amounts of Goodwill by Segment (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Goodwill [Roll Forward] | ||
Goodwill, beginning balance | $ 5,238,726 | $ 4,224,900 |
Goodwill acquired | 197,800 | 1,043,800 |
Purchase price allocation adjustments and other | 1,800 | 1,900 |
Foreign currency translation adjustments | (65,700) | (31,900) |
Goodwill, ending balance | 5,372,562 | 5,238,726 |
EIG | ||
Goodwill [Roll Forward] | ||
Goodwill, beginning balance | 4,073,800 | 3,050,300 |
Goodwill acquired | 197,800 | 1,037,900 |
Purchase price allocation adjustments and other | 1,800 | 1,900 |
Foreign currency translation adjustments | (37,300) | (16,300) |
Goodwill, ending balance | 4,236,100 | 4,073,800 |
EMG | ||
Goodwill [Roll Forward] | ||
Goodwill, beginning balance | 1,164,900 | 1,174,600 |
Goodwill acquired | 0 | 5,900 |
Purchase price allocation adjustments and other | 0 | 0 |
Foreign currency translation adjustments | (28,400) | (15,600) |
Goodwill, ending balance | $ 1,136,500 | $ 1,164,900 |
Goodwill and Other Intangible_4
Goodwill and Other Intangible Assets - Other Intangible Assets (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Finite-Lived Intangible Assets [Line Items] | ||
Definite-lived intangible assets (subject to amortization) | $ 3,792,457 | $ 3,656,087 |
Accumulated amortization | (1,340,028) | (1,161,794) |
Net intangible assets subject to amortization | 2,452,429 | 2,494,293 |
Total | 3,342,085 | 3,368,629 |
Trademarks and trade names | ||
Finite-Lived Intangible Assets [Line Items] | ||
Trademarks and trade names | 889,656 | 874,336 |
Patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Definite-lived intangible assets (subject to amortization) | 46,418 | 48,071 |
Accumulated amortization | (37,215) | (37,713) |
Purchased technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Definite-lived intangible assets (subject to amortization) | 722,277 | 677,896 |
Accumulated amortization | (269,155) | (235,989) |
Customer lists | ||
Finite-Lived Intangible Assets [Line Items] | ||
Definite-lived intangible assets (subject to amortization) | 3,023,762 | 2,930,120 |
Accumulated amortization | $ (1,033,658) | $ (888,092) |
Goodwill and Intangible Assets
Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Amortization expense | $ 205.8 | $ 183.6 | $ 154 |
Future amortization expense, year one | 204 | ||
Future amortization expense, year two | 204 | ||
Future amortization expense, year three | 204 | ||
Future amortization expense, year four | 204 | ||
Future amortization expense, year five | $ 204 |
Other Consolidated Balance Sh_3
Other Consolidated Balance Sheet Information - Other Consolidated Balance Sheet Information (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
INVENTORIES, NET | ||||
Finished goods and parts | $ 130,989 | $ 89,985 | ||
Work in process | 138,043 | 122,356 | ||
Raw materials and purchased parts | 775,252 | 556,834 | ||
Total inventories | 1,044,284 | 769,175 | ||
PROPERTY, PLANT AND EQUIPMENT, NET | ||||
Land | 55,915 | 41,709 | ||
Buildings | 365,679 | 343,996 | ||
Machinery and equipment | 1,199,600 | 1,149,316 | ||
Property, plant and equipment, gross | 1,621,194 | 1,535,021 | ||
Less: Accumulated depreciation | (985,553) | (917,883) | ||
Property, plant and equipment, Net | 635,641 | 617,138 | ||
ACCRUED LIABILITIES AND OTHER | ||||
Employee compensation and benefits | 213,478 | 205,994 | ||
Product warranty obligation | 26,487 | 27,478 | $ 27,839 | $ 27,611 |
Realignment | 34,394 | 30,476 | ||
Short term lease liability | 46,366 | 47,353 | ||
Other | 114,419 | 132,036 | ||
Total accrued liabilities | $ 435,144 | $ 443,337 |
Income Taxes - Components of In
Income Taxes - Components of Income before Income Taxes and Details of Provision for Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income before income taxes: | |||
Domestic | $ 893,478 | $ 958,206 | $ 810,844 |
Foreign | 535,214 | 264,964 | 271,465 |
Total | 1,428,692 | 1,223,170 | 1,082,309 |
Current: | |||
Federal | 183,619 | 99,706 | 126,427 |
Foreign | 119,148 | 146,890 | 61,672 |
State | 34,201 | 16,282 | 19,932 |
Total current | 336,968 | 262,878 | 208,031 |
Deferred: | |||
Federal | (37,810) | 23,538 | (1,254) |
Foreign | (20,818) | (56,572) | (4,072) |
State | (9,190) | 3,273 | 7,165 |
Total deferred | (67,818) | (29,761) | 1,839 |
Total provision | $ 269,150 | $ 233,117 | $ 209,870 |
Income Taxes - Components of De
Income Taxes - Components of Deferred Tax Asset and Liability (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Noncurrent deferred tax asset liability | ||
Net operating loss carryforwards | $ (54,300) | |
Unremitted earnings | 60,400 | $ 186,400 |
Deferred tax liabilities, gross | 633,786 | 681,327 |
Less: Valuation allowance | 9,613 | 11,349 |
Deferred tax liabilities, net | 643,399 | 692,676 |
Portion included in non-current assets | 50,868 | 26,999 |
Gross non-current deferred tax liability | 694,267 | 719,675 |
Cumulative Effect, Period of Adoption, Adjustment | ||
Noncurrent deferred tax asset liability | ||
Deferred tax asset net | 34,100 | 33,300 |
Non Current | ||
Noncurrent deferred tax asset liability | ||
Differences in basis of property and accelerated depreciation | 43,594 | 44,199 |
Reserves not currently deductible | (131,958) | (118,578) |
Pensions | 66,558 | 63,329 |
Differences in basis of intangible assets and accelerated amortization | 726,525 | 768,542 |
Net operating loss carryforwards | (54,318) | (44,164) |
Share-based compensation | (13,279) | (12,728) |
Foreign Tax Credit Carryforwards | (2,317) | (2,291) |
Unremitted earnings | 12,429 | 11,361 |
Other | $ (13,448) | $ (28,343) |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of Effective Tax Rate to U.S. Federal Statutory Rate (Detail) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
U.S. Federal statutory rate | 21% | 21% | 21% |
State income taxes, net of federal income tax benefit | 1.60% | 1.50% | 2.30% |
Foreign operations, net | (1.00%) | (0.40%) | (1.40%) |
U.S. Benefits for Manufacturing, Export and credits | (2.90%) | (2.60%) | (1.90%) |
Uncertain Tax Items | 1% | (0.10%) | (1.30%) |
Stock compensation | (0.90%) | (1.70%) | (1.00%) |
U.S. Tax on Foreign Earnings | 0.50% | 3.90% | 2.20% |
U.S. General Basket FTC | (0.10%) | (2.90%) | (0.10%) |
Other | (0.40%) | 0.30% | (0.50%) |
Consolidated effective tax rate | 18.80% | 19.10% | 19.40% |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Contingency [Line Items] | ||||
Deferred income taxes | $ 35.9 | |||
Foreign earnings repatriated | 898 | |||
Unremitted earnings | 60.4 | $ 186.4 | ||
Net operating loss carryforwards | 54.3 | |||
Income tax benefit | 2.7 | |||
Tax benefits related to tax credit carryforwards | 9.3 | |||
Tax credit carryforwards | 2.9 | |||
Reduction in valuation allowance | 1.7 | |||
Deferred tax assets, operating loss carryforwards, foreign | 1.3 | |||
Gross unrecognized tax benefits | 174.7 | 147 | $ 100.7 | $ 109.1 |
The total amount of unrecognized tax benefits that would impact tax rate, if recognized | 128.5 | 110 | ||
Interest and penalties accrued related to uncertain tax positions | 12.4 | 9.1 | ||
Unrecognized tax expense (benefit), income tax penalties and interest | $ 3.2 | (2.5) | ||
Portion of tax liability incurred in domestic country | 64% | |||
Additions of tax, interest and penalties related to uncertain tax positions | $ 43.4 | 58.6 | ||
Tax and interest related to statute expirations and settlement of prior uncertain positions reversed | 4.4 | 35.2 | ||
Decrease in deferred liabilities | 27.7 | |||
Increase of income tax expense | 23.1 | |||
Additions for tax positions of prior years | 2.1 | 34.9 | $ 6.2 | |
Amount of tax, interest and penalties classified as a noncurrent liability | 173.2 | |||
Decrease in deferred tax assets | 13.9 | |||
Changes in Net Operating Losses | ||||
Income Tax Contingency [Line Items] | ||||
Reduction in valuation allowance | 0.3 | |||
Foreign | ||||
Income Tax Contingency [Line Items] | ||||
Deferred income tax assets, net | 12.4 | 11.4 | ||
Operating loss carryforwards | 41.4 | $ 2.7 | ||
Operating loss carryforwards valuation allowance | 2.4 | |||
Federal | ||||
Income Tax Contingency [Line Items] | ||||
Operating loss carryforwards | 2.2 | |||
Tax credit carryforwards valuation allowance | 0.6 | |||
Federal | Tax Credits | ||||
Income Tax Contingency [Line Items] | ||||
Reduction in valuation allowance | 2.3 | |||
State and Local Jurisdiction | ||||
Income Tax Contingency [Line Items] | ||||
Operating loss carryforwards | 10.7 | |||
Tax credit carryforwards valuation allowance | $ 6.4 |
Income Taxes - Reconciliation_2
Income Taxes - Reconciliation of Liability for Uncertain Tax Positions (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Balance at the beginning of the year | $ 147 | $ 100.7 | $ 109.1 |
Additions for tax positions related to the current year | 29.3 | 41.4 | 15.6 |
Additions for tax positions of prior years | 2.1 | 34.9 | 6.2 |
Reductions for tax positions of prior years | (1) | (1.5) | (0.3) |
Reductions related to settlements with taxing authorities | (0.2) | (0.1) | (0.5) |
Reductions due to statute expirations | (2.5) | (28.4) | (29.4) |
Balance at the end of the year | $ 174.7 | $ 147 | $ 100.7 |
Debt - Long-term Debt (Detail)
Debt - Long-term Debt (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Oct. 31, 2016 | Aug. 31, 2015 | Jun. 30, 2015 | Sep. 30, 2014 |
Debt Instrument [Line Items] | ||||||
Less: Debt issuance costs | $ (7,395) | $ (5,919) | ||||
Total debt, net | 2,385,007 | 2,544,241 | ||||
Less: Current portion, net | (226,079) | (315,093) | ||||
Total long-term debt, net | 2,158,928 | 2,229,148 | ||||
Interest rate on senior notes | 1.53% | |||||
U.S. dollar 3.73% senior notes due September 2024 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | 300,000 | 300,000 | ||||
Interest rate on senior notes | 3.73% | |||||
U.S. dollar 3.91% senior notes due June 2025 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | 50,000 | 50,000 | ||||
Interest rate on senior notes | 3.91% | |||||
U.S. dollar 3.96% senior notes due August 2025 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | 100,000 | 100,000 | ||||
Interest rate on senior notes | 3.96% | |||||
U.S. dollar 4.18% senior notes due December 2025 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 275,000 | 275,000 | ||||
Interest rate on senior notes | 4.18% | |||||
U.S. dollar 3.83% senior notes due September 2026 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 100,000 | 100,000 | ||||
Interest rate on senior notes | 3.83% | |||||
U.S. dollar 4.32% senior notes due December 2027 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 250,000 | 250,000 | ||||
Interest rate on senior notes | 4.32% | |||||
U.S. dollar 4.37% senior notes due December 2028 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 50,000 | 50,000 | ||||
Interest rate on senior notes | 4.37% | |||||
U.S. dollar 3.98% senior notes due September 2029 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 100,000 | 100,000 | ||||
Interest rate on senior notes | 3.98% | |||||
U.S. dollar 4.45% senior notes due August 2035 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | 50,000 | 50,000 | ||||
Interest rate on senior notes | 4.45% | |||||
British pound 2.59% senior note due November 2028 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 181,157 | 203,046 | ||||
Interest rate on senior notes | 2.59% | |||||
British pound 2.70% senior note due November 2031 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 90,579 | 101,510 | ||||
Interest rate on senior notes | 2.70% | |||||
Euro 1.34% senior notes due October 2026 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 320,808 | 341,284 | ||||
Interest rate on senior notes | 1.34% | |||||
Euro 1.71% senior notes due December 2027 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 80,205 | 85,323 | ||||
Interest rate on senior notes | 1.71% | |||||
Euro 1.53% senior notes due October 2028 | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 213,894 | 227,541 | ||||
Interest rate on senior notes | 1.53% | |||||
Revolving credit facility borrowings | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 219,000 | 314,480 | ||||
Other, principally foreign | ||||||
Debt Instrument [Line Items] | ||||||
Total debt, gross | $ 11,759 | $ 1,976 |
Debt - Additional Information (
Debt - Additional Information (Detail) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||
Jan. 21, 2019 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2021 CHF (SFr) | Dec. 31, 2022 USD ($) | Dec. 31, 2018 USD ($) | Dec. 31, 2018 EUR (€) | Dec. 31, 2018 EUR (€) | Nov. 30, 2016 GBP (£) | Oct. 31, 2016 EUR (€) | Aug. 31, 2015 USD ($) | Jun. 30, 2015 USD ($) | Sep. 30, 2014 USD ($) | Dec. 31, 2011 | |
Debt Instrument [Line Items] | |||||||||||||
Maturities of long-term debt outstanding year one | $ 300,000,000 | ||||||||||||
Maturities of long-term debt outstanding year two | 425,000,000 | ||||||||||||
Maturities of long-term debt outstanding year three | 420,800,000 | ||||||||||||
Maturities of long-term debt outstanding year four | 330,200,000 | $ 300,000,000 | |||||||||||
Maturities of long-term debt outstanding year five | 445,100,000 | ||||||||||||
Maturities of long-term debt outstanding thereafter | $ 240,600,000 | ||||||||||||
Debt instrument, face amount | € | € 200,000,000 | ||||||||||||
Interest rate on senior notes | 1.53% | ||||||||||||
Revolving credit facility expiration period | 5 years | ||||||||||||
Weighted average interest rate on total debt borrowings outstanding | 3.10% | 3.40% | |||||||||||
Revolving Credit Facility Borrowings | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Total borrowing capacity under revolving credit facility | $ 1,500,000,000 | $ 2,300,000,000 | |||||||||||
Additional borrowing capacity under revolving credit facility | 700,000,000 | ||||||||||||
Available borrowing capacity under revolving credit facility | 2,745,200,000 | ||||||||||||
Borrowings outstanding | $ 314,500,000 | $ 219,000,000 | |||||||||||
Percentage of weighted average interest rate on revolving credit facility | 1.34% | 3.57% | |||||||||||
Revolving Credit Facility Borrowings | Letter of Credit | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Borrowings outstanding | $ 38,000,000 | $ 35,800,000 | |||||||||||
Accordion Feature | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Available borrowing capacity under revolving credit facility | 700,000,000 | ||||||||||||
Foreign Subsidiaries | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Available borrowing capacity under revolving credit facility | 56,800,000 | 64,100,000 | |||||||||||
Borrowings outstanding | 2,000,000 | 11,800,000 | |||||||||||
Swiss franc 2.44% senior note due December 2021 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Extinguishment of debt, amount | 59,700,000 | SFr 55,000,000 | |||||||||||
Interest rate on senior notes | 2.44% | ||||||||||||
Senior Notes | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | $ 575,000,000 | € 75,000,000 | |||||||||||
Proceeds from funding | $ 100,000,000 | 80,200,000 | $ 475,000,000 | € 75,000,000 | |||||||||
Weighted average interest rate | 3.93% | 3.93% | |||||||||||
Senior Notes | 1.34% Due October 2026 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | 320,800,000 | € 300,000,000 | |||||||||||
Interest rate on senior notes | 1.34% | ||||||||||||
Senior Notes | 1.53% Due October 2028 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | 213,900,000 | ||||||||||||
Senior Notes | 2.59% Due November 2028 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | 181,200,000 | £ 150,000,000 | |||||||||||
Interest rate on senior notes | 2.59% | ||||||||||||
Senior Notes | 2.70% Due November 2031 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | 90,600,000 | £ 75,000,000 | |||||||||||
Interest rate on senior notes | 2.70% | ||||||||||||
U.S. dollar 3.73% senior notes due September 2024 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Interest rate on senior notes | 3.73% | ||||||||||||
Total debt, gross | 300,000,000 | 300,000,000 | |||||||||||
U.S. dollar 3.83% senior notes due September 2026 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | $ 100,000,000 | ||||||||||||
Interest rate on senior notes | 3.83% | ||||||||||||
Total debt, gross | 100,000,000 | 100,000,000 | |||||||||||
U.S. dollar 3.98% senior notes due September 2029 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Interest rate on senior notes | 3.98% | ||||||||||||
Total debt, gross | 100,000,000 | 100,000,000 | |||||||||||
U.S. dollar 3.91% senior notes due June 2025 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | $ 50,000,000 | ||||||||||||
Interest rate on senior notes | 3.91% | ||||||||||||
Total debt, gross | 50,000,000 | 50,000,000 | |||||||||||
U.S. dollar 3.96% senior notes due August 2025 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | $ 100,000,000 | ||||||||||||
Interest rate on senior notes | 3.96% | ||||||||||||
Total debt, gross | 100,000,000 | 100,000,000 | |||||||||||
U.S. dollar 4.45% senior notes due August 2035 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | $ 50,000,000 | ||||||||||||
Interest rate on senior notes | 4.45% | ||||||||||||
Total debt, gross | $ 50,000,000 | 50,000,000 | |||||||||||
Secured Debt | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt instrument, face amount | $ 800,000,000 |
Share-Based Compensation - Addi
Share-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 12 Months Ended | |||
Jan. 01, 2018 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Aggregate intrinsic value of stock options exercised | $ 50.3 | $ 59.1 | $ 63.7 | |
Total fair value of stock options vested | $ 11.4 | 13.7 | 12.9 | |
Stock Options Granted Prior Date | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Contractual term of stock options | 7 years | |||
Beginning in 2018 Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Contractual term of stock options | 10 years | |||
Restricted Stock Granted Prior Date | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Cliff vesting period | 4 years | |||
Non Employee Directors Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Cliff vesting period | 2 years | |||
Performance Restricted Stock Units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected future pre-tax compensation expense, nonvested stock options | $ 4 | |||
Nonvested stock options outstanding | 0.3 | |||
Weighted average period to recognize expected future pre-tax compensation expense (in years) | 1 year | |||
Weighted average fair value, per share | $ 134.69 | |||
Performance Restricted Stock Units | Officers And Key Management Employees | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Cliff vesting period | 3 years | |||
Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected future pre-tax compensation expense, nonvested restricted shares | $ 27 | |||
Nonvested stock options outstanding | 0.4 | |||
Weighted average period to recognize expected future pre-tax compensation expense (in years) | 2 years | |||
Total fair value of vested restricted stock | $ 17.7 | $ 28.6 | $ 14.4 | |
Weighted average fair value, per share | $ 134.52 | $ 122.60 | ||
Restricted Stock | Stock Options Granted Prior Date | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 33.33% | |||
Restricted Stock | Beginning in 2018 Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 33.33% | |||
Restricted Stock | Share-based Payment Arrangement, Tranche Three | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 33.33% | |||
Non Vested Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected future pre-tax compensation expense, nonvested stock options | $ 18 | |||
Nonvested stock options outstanding | 1.1 | |||
Weighted average period to recognize expected future pre-tax compensation expense (in years) | 2 years | |||
Non Vested Restricted Stock | Stock Options Granted Prior Date | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 33.33% | 25% | ||
Non Vested Restricted Stock | Beginning in 2018 Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 33.33% | 25% | ||
Non Vested Restricted Stock | Share-based Payment Arrangement, Tranche Three | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 33.33% | 25% | ||
Non Vested Restricted Stock | Share-based Payment Arrangement, Tranche Four | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 25% | |||
Restricted Stock Units (RSUs) | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Consecutive trading days | 5 days | |||
Minimum | Performance Restricted Stock Units | Officers And Key Management Employees | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 0% | |||
Maximum | Performance Restricted Stock Units | Officers And Key Management Employees | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation, vesting rate | 200% |
Share-Based Compensation - Tota
Share-Based Compensation - Total Share-Based Compensation Expense (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-Based Payment Arrangement [Abstract] | |||
Stock option expense | $ 13,021 | $ 12,733 | $ 13,695 |
Restricted stock expense | 20,115 | 21,393 | 17,997 |
PRSU expense | 14,239 | 11,977 | 9,873 |
Total pre-tax expense | $ 47,375 | $ 46,103 | $ 41,565 |
Share-Based Compensation - Weig
Share-Based Compensation - Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted (Detail) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-Based Payment Arrangement [Abstract] | |||
Expected volatility | 24.50% | 24.20% | 22.20% |
Expected term (years) | 5 years | 5 years | 5 years |
Risk-free interest rate | 2.33% | 0.85% | 0.52% |
Expected dividend yield | 0.65% | 0.66% | 1.14% |
Black-Scholes-Merton fair value per stock option granted (in USD per share) | $ 32.54 | $ 25.63 | $ 11.01 |
Share-Based Compensation - Summ
Share-Based Compensation - Summary of Stock Option Activity and Related Information (Detail) $ / shares in Units, shares in Thousands, $ in Millions | 12 Months Ended |
Dec. 31, 2022 USD ($) $ / shares shares | |
Shares | |
Outstanding at the beginning of the year (in shares) | shares | 3,352 |
Granted (in shares) | shares | 608 |
Exercised (in shares) | shares | (788) |
Forfeited (in shares) | shares | (107) |
Expired (in shares) | shares | (5) |
Outstanding at the end of the year (in shares) | shares | 3,060 |
Exercisable at the end of the year (in shares) | shares | 1,944 |
Weighted Average Exercise Price | |
Weighted average exercise price, Outstanding at the beginning of the year (in USD per share) | $ / shares | $ 76.08 |
Weighted average exercise price, Granted (in USD per share) | $ / shares | 134.69 |
Weighted average exercise price, Exercised (in USD per share) | $ / shares | 63.75 |
Weighted average exercise price, Forfeited (in USD per share) | $ / shares | 108.79 |
Weighted average exercise price, Expired (in USD per share) | $ / shares | 101.38 |
Weighted average exercise price, Outstanding at the end of the year (in USD per share) | $ / shares | 79.46 |
Weighted average exercise price, Exercisable at the end of the year (in USD per share) | $ / shares | $ 75 |
Weighted Average Remaining Contractual Life | |
Weighted average remaining contractual life, Outstanding at the end of the year (in years) | 6 years 6 months |
Weighted average remaining contractual life, Exercisable at the end of the year (in years) | 5 years 4 months 24 days |
Aggregate Intrinsic Value | |
Aggregate intrinsic value, Outstanding at the end of the year | $ | $ 153 |
Aggregate intrinsic value, Exercisable at the end of the year | $ | $ 125.8 |
Share-Based Compensation - Su_2
Share-Based Compensation - Summary of Nonvested Stock Option Activity and Related Information (Detail) - Stock Option shares in Thousands | 12 Months Ended |
Dec. 31, 2022 $ / shares shares | |
Shares | |
Non-vested stock options outstanding at the beginning of the year (in shares) | shares | 1,292 |
Nonvested stock options, granted (in shares) | shares | 608 |
Nonvested stock options, Vested (in shares) | shares | (677) |
Nonvested stock options, Forfeited (in shares) | shares | (107) |
Non-vested stock options outstanding at the end of the year (in shares) | shares | 1,116 |
Weighted Average Grant Date Fair Value | |
Non-vested stock options outstanding at the beginning of the year, weighted average grant date fair value (in USD per share) | $ / shares | $ 18.41 |
Weighted average grant date fair value, Granted (in USD per share) | $ / shares | 32.54 |
Weighted average grant date fair value, Vested (in USD per share) | $ / shares | 16.78 |
Weighted average grant date fair value, Forfeited (in USD per share) | $ / shares | 23.86 |
Non-vested stock options outstanding at the the end of the year, weighted average grant date fair value (in USD per share) | $ / shares | $ 26.57 |
Share-Based Compensation - Su_3
Share-Based Compensation - Summary of Nonvested Restricted Stock Activity and Related Information (Detail) - $ / shares shares in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Shares | ||
Performance assumption change (in shares) | 66 | |
Weighted Average Grant Date Fair Value | ||
Performance assumption change (in USD per share) | $ 81.76 | |
Restricted Shares | ||
Shares | ||
Non-vested restricted stock outstanding at the beginning of the year (in shares) | 413 | |
Nonvested restricted stock, Granted (in shares) | 184 | |
Nonvested restricted stock, Vested (in shares) | (195) | |
Nonvested restricted stock, Forfeited (in shares) | (46) | |
Non-vested restricted stock outstanding at the end of the year (in shares) | 356 | 413 |
Weighted Average Grant Date Fair Value | ||
Non-vested restricted stock outstanding at the beginning of the year, weighted average grant date fair value (in USD per share) | $ 96.07 | |
Weighted average grant date fair value, Granted (in USD per share) | 134.52 | $ 122.60 |
Weighted average grant date fair value, Vested (in USD per share) | 90.78 | |
Weighted average grant date fair value, Forfeited (in USD per share) | 109.08 | |
Non-vested restricted stock outstanding at the end of the year, weighted average grant date fair value (in USD per share) | $ 117.18 | $ 96.07 |
Performance Restricted Stock Units | ||
Shares | ||
Non-vested restricted stock outstanding at the beginning of the year (in shares) | 289 | |
Nonvested restricted stock, Granted (in shares) | 87 | |
Nonvested restricted stock, Vested (in shares) | (161) | |
Nonvested restricted stock, Forfeited (in shares) | (6) | |
Non-vested restricted stock outstanding at the end of the year (in shares) | 275 | 289 |
Weighted Average Grant Date Fair Value | ||
Non-vested restricted stock outstanding at the beginning of the year, weighted average grant date fair value (in USD per share) | $ 85.29 | |
Weighted average grant date fair value, Granted (in USD per share) | 134.69 | |
Weighted average grant date fair value, Vested (in USD per share) | 81.76 | |
Weighted average grant date fair value, Forfeited (in USD per share) | 98.07 | |
Non-vested restricted stock outstanding at the end of the year, weighted average grant date fair value (in USD per share) | $ 101.98 | $ 85.29 |
Retirement Plans and Other Po_3
Retirement Plans and Other Postretirement Benefits - Additional Information (Detail) - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Percentage of minimum employee contributions | 20% | ||
Percentage of maximum employee contributions | 100% | ||
Percentage of employee contributions for eligible compensation, Minimum | 1% | ||
Percentage of employee contributions for eligible compensation, Maximum | 8% | ||
Defined benefit plan contributions by employer employee match | $ 1,200 | ||
Market share of treasury stock held (in shares) | 352,601 | 384,788 | |
Market value of treasury stock held | $ 49,300,000 | $ 56,600,000 | |
Percentage of equity securities in company common stock included in plan assets | 8.70% | 8.10% | |
Estimated future benefit payments, 2023 | $ 42,700,000 | ||
Estimated future benefit payments, 2024 | 43,300,000 | ||
Estimated future benefit payments, 2025 | 42,900,000 | ||
Estimated future benefit payments, 2026 | 42,800,000 | ||
Estimated future benefit payments, 2027 | 42,400,000 | ||
Estimated future benefit payments, 2026-2030 | 208,300,000 | ||
Amount deferred under the compensation plan, including income earned | $ 31,800,000 | $ 28,400,000 | |
Environmental loss contingency statement of financial position extensible enumeration not disclosed flag | consolidated financial statements | consolidated financial statements | |
Minimum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan estimated future employer contributions in next fiscal year | $ 7,000,000 | ||
Maximum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan estimated future employer contributions in next fiscal year | $ 11,000,000 | ||
U.S. Defined Benefit Pension Plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Expected long-term return on plan assets | 6.75% | 6.75% | 7% |
Assumed rate of return next year | 7.59% | ||
U.S. Defined Benefit Pension Plans | Equity Securities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Target allocations for the U.S. and foreign benefits plans | 50% | ||
U.S. Defined Benefit Pension Plans | Fixed Income Securities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Target allocations for the U.S. and foreign benefits plans | 20% | ||
U.S. Defined Benefit Pension Plans | Other Securities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Target allocations for the U.S. and foreign benefits plans | 30% | ||
Foreign Defined Benefit Pension Plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Expected long-term return on plan assets | 5.85% | 5.47% | 5.97% |
Assumed rate of return next year | 6.41% | ||
Foreign Defined Benefit Pension Plans | Equity Securities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Target allocations for the U.S. and foreign benefits plans | 23% | ||
Foreign Defined Benefit Pension Plans | Fixed Income Securities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Target allocations for the U.S. and foreign benefits plans | 21% | ||
Foreign Defined Benefit Pension Plans | Other Securities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Target allocations for the U.S. and foreign benefits plans | 5% | ||
Foreign Defined Benefit Pension Plans | Multi Asset Funds | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Target allocations for the U.S. and foreign benefits plans | 51% |
Retirement Plans and Other Po_4
Retirement Plans and Other Postretirement Benefits - Net Projected Benefit Obligation and Fair Value of Plan Assets for Funded and Unfunded Defined Benefit Plans (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Change in projected benefit obligation: | |||
Net projected benefit obligation at the beginning of the year | $ 837,195 | ||
Service cost | 4,919 | $ 6,985 | $ 7,261 |
Interest cost | 20,124 | 18,532 | 22,611 |
Net projected benefit obligation at the end of the year | 581,887 | 837,195 | |
Change in plan assets: | |||
Fair value of plan assets at the beginning of the year | 967,915 | ||
Fair value of plan assets at the end of the year | 728,641 | 967,915 | |
U.S. Defined Benefit Pension Plans | Pension Plan | |||
Change in projected benefit obligation: | |||
Net projected benefit obligation at the beginning of the year | 504,773 | 532,357 | |
Service cost | 2,067 | 2,767 | |
Interest cost | 14,889 | 14,074 | |
Actuarial (gains) losses | (106,159) | (12,593) | |
Gross benefits paid | (32,090) | (31,832) | |
Acquisition | (337) | 0 | |
Net projected benefit obligation at the end of the year | 383,143 | 504,773 | 532,357 |
Change in plan assets: | |||
Fair value of plan assets at the beginning of the year | 701,627 | 662,298 | |
Actual return on plan assets | (101,381) | 70,540 | |
Employer contributions | 1,230 | 621 | |
Gross benefits paid | (32,090) | (31,832) | |
Acquisition | (337) | 0 | |
Fair value of plan assets at the end of the year | 569,049 | 701,627 | 662,298 |
Foreign Defined Benefit Pension Plans | |||
Change in plan assets: | |||
Fair value of plan assets at the beginning of the year | 266,288 | ||
Fair value of plan assets at the end of the year | 159,592 | 266,288 | |
Foreign Defined Benefit Pension Plans | Pension Plan | |||
Change in projected benefit obligation: | |||
Net projected benefit obligation at the beginning of the year | 332,422 | 351,584 | |
Service cost | 2,852 | 4,218 | |
Interest cost | 5,235 | 4,458 | |
Foreign currency translation adjustments | (31,367) | (6,580) | |
Employee contributions | 0 | 76 | |
Actuarial (gains) losses | (100,201) | (10,199) | |
Expenses paid from assets | (686) | (1,121) | |
Gross benefits paid | (9,409) | (10,426) | |
Settlements | (102) | 0 | |
Curtailments | 0 | 412 | |
Net projected benefit obligation at the end of the year | 198,744 | 332,422 | 351,584 |
Change in plan assets: | |||
Fair value of plan assets at the beginning of the year | 266,288 | 250,735 | |
Actual return on plan assets | (77,643) | 20,184 | |
Employer contributions | 7,729 | 9,656 | |
Employee contributions | 0 | 76 | |
Foreign currency translation adjustments | (26,585) | (2,816) | |
Expenses paid from assets | (686) | (1,121) | |
Settlements | (102) | 0 | |
Gross benefits paid | (9,409) | (10,426) | |
Fair value of plan assets at the end of the year | $ 159,592 | $ 266,288 | $ 250,735 |
Retirement Plans and Other Po_5
Retirement Plans and Other Postretirement Benefits - Accumulated Benefit Obligation ("ABO") (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
U.S. Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Accumulated benefit obligation | $ 377,848 | $ 496,870 |
U.S. Defined Benefit Pension Plans | Funded plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Accumulated benefit obligation | 374,979 | 492,957 |
U.S. Defined Benefit Pension Plans | Unfunded plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Accumulated benefit obligation | 2,869 | 3,913 |
Foreign Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Accumulated benefit obligation | 198,419 | 331,774 |
Foreign Defined Benefit Pension Plans | Funded plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Accumulated benefit obligation | 167,495 | 284,013 |
Foreign Defined Benefit Pension Plans | Unfunded plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Accumulated benefit obligation | $ 30,924 | $ 47,761 |
Retirement Plans and Other Po_6
Retirement Plans and Other Postretirement Benefits - Weighted Average Assumptions Used to Determine Benefit Obligations (Detail) - Pension Plan | Dec. 31, 2022 | Dec. 31, 2021 |
U.S. Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Discount rate | 5.65% | 3.02% |
Rate of compensation increase (where applicable) | 3.75% | 3.75% |
Foreign Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Discount rate | 4.73% | 1.78% |
Rate of compensation increase (where applicable) | 2.50% | 2.50% |
Retirement Plans and Other Po_7
Retirement Plans and Other Postretirement Benefits - Fair Value of Plan Assets (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | $ 728,641 | $ 967,915 |
U.S. Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 569,049 | 701,627 |
U.S. Defined Benefit Pension Plans | Municipal bonds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 711 | 676 |
U.S. Defined Benefit Pension Plans | Corporate debt instruments | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 6,192 | 4,053 |
U.S. Defined Benefit Pension Plans | Corporate debt instruments – Preferred | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 13,425 | 11,265 |
U.S. Defined Benefit Pension Plans | Corporate stocks – Common | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 53,629 | 67,975 |
U.S. Defined Benefit Pension Plans | Registered investment companies | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 155,541 | 150,535 |
U.S. Defined Benefit Pension Plans | U.S. Government securities | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 1,253 | 663 |
U.S. Defined Benefit Pension Plans | Total investments | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 230,751 | 235,167 |
U.S. Defined Benefit Pension Plans | Investments measured at net asset value | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 338,298 | 466,460 |
Level 1 | U.S. Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 209,170 | 218,510 |
Level 1 | U.S. Defined Benefit Pension Plans | Corporate stocks – Common | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 53,629 | 67,975 |
Level 1 | U.S. Defined Benefit Pension Plans | Registered investment companies | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 155,541 | 150,535 |
Level 1 | U.S. Defined Benefit Pension Plans | U.S. Government securities | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 0 | |
Level 1 | U.S. Defined Benefit Pension Plans | Total investments | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 209,170 | 218,510 |
Level 2 | U.S. Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 21,581 | 16,657 |
Level 2 | U.S. Defined Benefit Pension Plans | Municipal bonds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 711 | 676 |
Level 2 | U.S. Defined Benefit Pension Plans | Corporate debt instruments | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 6,192 | 4,053 |
Level 2 | U.S. Defined Benefit Pension Plans | Corporate debt instruments – Preferred | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 13,425 | 11,265 |
Level 2 | U.S. Defined Benefit Pension Plans | Registered investment companies | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 0 | |
Level 2 | U.S. Defined Benefit Pension Plans | U.S. Government securities | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | 1,253 | 663 |
Level 2 | U.S. Defined Benefit Pension Plans | Total investments | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Fair value of plan assets | $ 21,581 | $ 16,657 |
Retirement Plans and Other Po_8
Retirement Plans and Other Postretirement Benefits - Fair Value of Plan Assets for Foreign Defined Benefit Pension Plans (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | $ 728,641 | $ 967,915 | |
Foreign Defined Benefit Pension Plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 159,592 | 266,288 | |
Foreign Defined Benefit Pension Plans | Life insurance | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 13,043 | 18,806 | |
Foreign Defined Benefit Pension Plans | Total investments | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 13,043 | 18,806 | |
Foreign Defined Benefit Pension Plans | Investments measured at net asset value | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 146,549 | 247,482 | |
Level 3 | Foreign Defined Benefit Pension Plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 13,043 | 18,806 | |
Level 3 | Foreign Defined Benefit Pension Plans | Life insurance | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 13,043 | 18,806 | $ 20,908 |
Level 3 | Foreign Defined Benefit Pension Plans | Total investments | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | $ 13,043 | $ 18,806 |
Retirement Plans and Other Po_9
Retirement Plans and Other Postretirement Benefits - Summary of Changes of Fair Value of Foreign Plans' Investments Using Significant Unobservable Inputs (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward] | ||
Fair value of plan assets at the beginning of the year | $ 967,915 | |
Actual return on assets: | ||
Fair value of plan assets at the end of the year | 728,641 | $ 967,915 |
Foreign Defined Benefit Pension Plans | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward] | ||
Fair value of plan assets at the beginning of the year | 266,288 | |
Actual return on assets: | ||
Fair value of plan assets at the end of the year | 159,592 | 266,288 |
Foreign Defined Benefit Pension Plans | Life insurance | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward] | ||
Fair value of plan assets at the beginning of the year | 18,806 | |
Actual return on assets: | ||
Fair value of plan assets at the end of the year | 13,043 | 18,806 |
Level 3 | Foreign Defined Benefit Pension Plans | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward] | ||
Fair value of plan assets at the beginning of the year | 18,806 | |
Actual return on assets: | ||
Fair value of plan assets at the end of the year | 13,043 | 18,806 |
Level 3 | Foreign Defined Benefit Pension Plans | Life insurance | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward] | ||
Fair value of plan assets at the beginning of the year | 18,806 | 20,908 |
Actual return on assets: | ||
Unrealized losses relating to instruments still held at the end of the year | (5,763) | (2,102) |
Realized gains (losses) relating to assets sold during the year | 0 | 0 |
Purchases, sales, issuances and settlements, net | 0 | 0 |
Fair value of plan assets at the end of the year | $ 13,043 | $ 18,806 |
Retirement Plans and Other P_10
Retirement Plans and Other Postretirement Benefits - Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets (Detail) - Pension Plan - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
U.S. Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Projected benefit obligation exceeds fair value of assets, projected benefit obligation | $ 4,043 | $ 6,234 |
Projected benefit obligation exceeds fair value of assets, fair value of plan assets | 707 | 1,239 |
Accumulated benefit obligation exceeds fair value of assets, projected benefit obligation | 4,043 | 6,234 |
Accumulated benefit obligation exceeds fair value of assets, fair value of plan assets | 707 | 1,239 |
Foreign Defined Benefit Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Projected benefit obligation exceeds fair value of assets, projected benefit obligation | 162,105 | 272,245 |
Projected benefit obligation exceeds fair value of assets, fair value of plan assets | 120,056 | 200,862 |
Accumulated benefit obligation exceeds fair value of assets, projected benefit obligation | 161,780 | 271,596 |
Accumulated benefit obligation exceeds fair value of assets, fair value of plan assets | $ 120,056 | $ 200,862 |
Retirement Plans and Other P_11
Retirement Plans and Other Postretirement Benefits - Funded Status of Plan and Amounts Recognized in Balance Sheet (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Funded status asset (liability): | ||
Fair value of plan assets | $ 728,641 | $ 967,915 |
Projected benefit obligation | (581,887) | (837,195) |
Funded status at the end of the year | 146,754 | 130,720 |
Amounts recognized in the consolidated balance sheet consisted of: | ||
Non-current asset for pension benefits (other assets) | 192,140 | 207,099 |
Current liabilities for pension benefits | (2,700) | (2,133) |
Non-current liability for pension benefits | (42,686) | (74,246) |
Net amount recognized at the end of the year | $ 146,754 | $ 130,720 |
Retirement Plans and Other P_12
Retirement Plans and Other Postretirement Benefits - Amounts Recognized in Accumulated Other Comprehensive Income, Net of Taxes (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Defined Benefit Plan Disclosure [Line Items] | ||
Total recognized | $ 206,821 | $ 195,079 |
Net actuarial loss | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Total recognized | 205,193 | 193,220 |
Prior service costs | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Total recognized | 1,625 | 1,855 |
Transition asset | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Total recognized | $ 3 | $ 4 |
Retirement Plans and Other P_13
Retirement Plans and Other Postretirement Benefits - Components of Net Periodic Pension Benefit Expense (Income) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Defined benefit plans: | |||
Service cost | $ 4,919 | $ 6,985 | $ 7,261 |
Interest cost | 20,124 | 18,532 | 22,611 |
Expected return on plan assets | (60,104) | (56,752) | (54,629) |
Curtailment | 0 | 3,151 | 0 |
Settlement | (58) | 0 | 0 |
Amortization of: | |||
Net actuarial loss | 8,531 | 16,353 | 15,479 |
Prior service costs | 100 | 456 | 486 |
Transition asset | 1 | 1 | 1 |
Total net periodic benefit income | (26,487) | (11,274) | (8,791) |
Other plans: | |||
Defined contribution plans | 39,326 | 31,149 | 30,829 |
Foreign plans and other | 8,373 | 8,454 | 7,902 |
Total other plans | 47,699 | 39,603 | 38,731 |
Total net pension expense | $ 21,212 | $ 28,329 | $ 29,940 |
Defined benefit plan, net periodic benefit cost (credit) excluding service cost, statement of income or comprehensive income | Cost of sales, Other Nonoperating Income (Expense), Selling, general and administrative | Cost of sales, Other Nonoperating Income (Expense), Selling, general and administrative | Cost of sales, Other Nonoperating Income (Expense), Selling, general and administrative |
Retirement Plans and Other P_14
Retirement Plans and Other Postretirement Benefits - Weighted Average Assumptions Used to Determine Net Periodic Pension Benefit Expense (Detail) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
U.S. Defined Benefit Pension Plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Discount rate | 3.02% | 2.69% | 3.45% |
Expected return on plan assets | 6.75% | 6.75% | 7% |
Rate of compensation increase (where applicable) | 3.75% | 3.75% | 3.75% |
Foreign Defined Benefit Pension Plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Discount rate | 1.78% | 1.27% | 1.83% |
Expected return on plan assets | 5.85% | 5.47% | 5.97% |
Rate of compensation increase (where applicable) | 2.50% | 2.50% | 2.50% |
Contingencies - Additional Info
Contingencies - Additional Information (Detail) $ in Millions | 12 Months Ended | |
Dec. 31, 2022 USD ($) site | Dec. 31, 2021 USD ($) | |
Commitments and Contingencies Disclosure [Abstract] | ||
Number of non-owned sites Company is named Potentially Responsible Party | 13 | |
Number of non-owned sites the Company is identified as a de minimis party | 12 | |
Number of non Owned sites company is identified as de minimis party, settlement amount known | 8 | |
Number of non Owned sites company is identified as de minimis party, settlement amount unknown | 4 | |
Total environmental reserves | $ | $ 41 | $ 37.2 |
Increase (decrease) in environmental reserves | $ | 12 | |
Total expenses related to environmental matters | $ | $ 8.2 |
Leases and Other Commitments -
Leases and Other Commitments - Additional Information (Detail) - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
Lessee, Lease, Description [Line Items] | ||
Weighted-average remaining lease terms – operating leases (years) | 5 years 25 days | 5 years 4 months 9 days |
Purchase obligations outstanding | $ 1,119.7 | $ 890.9 |
Future payment obligations | 128 | |
Future payment obligations, guarantees | $ 12.4 | |
Minimum | ||
Lessee, Lease, Description [Line Items] | ||
Weighted-average remaining lease terms – operating leases (years) | 1 month | |
Maximum | ||
Lessee, Lease, Description [Line Items] | ||
Weighted-average remaining lease terms – operating leases (years) | 15 years |
Leases and Other Commitments _2
Leases and Other Commitments - Components of Lease Expense (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Leases [Abstract] | |||
Operating lease cost | $ 59,296 | $ 61,680 | $ 44,498 |
Variable lease cost | 11,096 | 7,724 | 4,526 |
Total lease cost | $ 70,392 | $ 69,404 | $ 49,024 |
Leases and Other Commitments _3
Leases and Other Commitments - Supplemental Balance Sheet Information Related to Leases (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Leases [Abstract] | ||
Right of use assets, net | $ 170,295 | $ 169,924 |
Operating lease, liability, current, statement of financial position | Accrued Liabilities and Other Liabilities | Accrued Liabilities and Other Liabilities |
Lease liabilities included in Accrued liabilities and other | $ 46,366 | $ 47,353 |
Operating lease, liability, noncurrent, statement of financial position | Other long-term liabilities | Other long-term liabilities |
Lease liabilities included in Other long-term liabilities | $ 129,227 | $ 129,101 |
Total lease liabilities | $ 175,593 | $ 176,454 |
Leases and Other Commitments _4
Leases and Other Commitments - Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | ||
Cash used in operations for operating leases | $ 54,724 | $ 55,657 |
Right-of-use assets obtained in exchange for new operating liabilities | $ 59,802 | $ 64,653 |
Weighted-average remaining lease terms – operating leases (years) | 5 years 25 days | 5 years 4 months 9 days |
Weighted-average discount rate – operating leases | 3.32% | 2.91% |
Leases and Other Commitments _5
Leases and Other Commitments - Maturities of lease liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Leases [Abstract] | ||
2023 | $ 51,740 | |
2024 | 41,047 | |
2025 | 31,338 | |
2026 | 23,770 | |
2027 | 15,467 | |
Thereafter | 29,523 | |
Total lease payments | 192,885 | |
Less: imputed interest | 17,292 | |
Operating lease liability | $ 175,593 | $ 176,454 |
Reportable Segments and Geogr_3
Reportable Segments and Geographic Areas Information - Additional Information (Detail) | 12 Months Ended |
Dec. 31, 2022 segment | |
Segment Reporting [Abstract] | |
Number of reportable segments | 2 |
Reportable Segments and Geogr_4
Reportable Segments and Geographic Areas Information - Reportable Segment Financial Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Segment operating income: | |||
Consolidated operating income | $ 1,500,692 | $ 1,308,670 | $ 1,027,884 |
Interest and other income (expenses), net | (72,000) | (85,500) | 54,425 |
Total | 1,428,692 | 1,223,170 | 1,082,309 |
Assets: | |||
Assets | 12,431,120 | 11,898,187 | |
Additions to property, plant and equipment: | |||
Additions to property, plant and equipment | 151,448 | 213,270 | 76,026 |
Depreciation and amortization: | |||
Depreciation and amortization | 319,427 | 292,112 | 255,275 |
Operating Segments | |||
Segment operating income: | |||
Consolidated operating income | 1,593,322 | 1,395,561 | 1,095,582 |
Assets: | |||
Assets | 12,048,482 | 11,311,484 | |
Additions to property, plant and equipment: | |||
Additions to property, plant and equipment | 131,691 | 202,853 | 75,019 |
Depreciation and amortization: | |||
Depreciation and amortization | 316,332 | 289,615 | 252,791 |
Operating Segments | EIG | |||
Segment operating income: | |||
Consolidated operating income | 1,089,729 | 958,183 | 770,620 |
Assets: | |||
Assets | 9,430,797 | 8,672,711 | |
Additions to property, plant and equipment: | |||
Additions to property, plant and equipment | 93,505 | 168,267 | 48,638 |
Depreciation and amortization: | |||
Depreciation and amortization | 238,436 | 210,118 | 174,494 |
Operating Segments | EMG | |||
Segment operating income: | |||
Consolidated operating income | 503,593 | 437,378 | 324,962 |
Assets: | |||
Assets | 2,617,685 | 2,638,773 | |
Additions to property, plant and equipment: | |||
Additions to property, plant and equipment | 38,186 | 34,586 | 26,381 |
Depreciation and amortization: | |||
Depreciation and amortization | 77,896 | 79,497 | 78,297 |
Corporate | |||
Segment operating income: | |||
Consolidated operating income | (92,630) | (86,891) | (67,698) |
Assets: | |||
Assets | 382,638 | 586,703 | |
Additions to property, plant and equipment: | |||
Additions to property, plant and equipment | 19,757 | 10,417 | 1,007 |
Depreciation and amortization: | |||
Depreciation and amortization | $ 3,095 | $ 2,497 | $ 2,484 |
Reportable Segments and Geogr_5
Reportable Segments and Geographic Areas Information - Reportable Segment Financial Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Segment Reporting [Abstract] | |||
Additions to property, plant and equipment from acquired business | $ 12.4 | $ 102.6 | $ 1.8 |
Reportable Segments and Geogr_6
Reportable Segments and Geographic Areas Information - Information about Company's Operations in Different Geographic Areas (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Long-lived assets from continuing operations (excluding intangible assets): | ||
Long-lived assets from continuing operations (excluding intangible assets) | $ 635,641 | $ 617,138 |
United States | ||
Long-lived assets from continuing operations (excluding intangible assets): | ||
Long-lived assets from continuing operations (excluding intangible assets) | 412,577 | 416,323 |
United Kingdom | ||
Long-lived assets from continuing operations (excluding intangible assets): | ||
Long-lived assets from continuing operations (excluding intangible assets) | 71,462 | 74,525 |
European Union countries | ||
Long-lived assets from continuing operations (excluding intangible assets): | ||
Long-lived assets from continuing operations (excluding intangible assets) | 89,993 | 87,117 |
Asia | ||
Long-lived assets from continuing operations (excluding intangible assets): | ||
Long-lived assets from continuing operations (excluding intangible assets) | 11,479 | 11,971 |
Other foreign countries | ||
Long-lived assets from continuing operations (excluding intangible assets): | ||
Long-lived assets from continuing operations (excluding intangible assets) | 50,130 | 27,202 |
Total international | ||
Long-lived assets from continuing operations (excluding intangible assets): | ||
Long-lived assets from continuing operations (excluding intangible assets) | $ 223,064 | $ 200,815 |
Additional Consolidated Incom_2
Additional Consolidated Income Statement and Cash Flow Information - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Interest and other investment income | $ 1 | $ 2 | $ 2.7 |
Income taxes paid | 299.3 | 245.5 | 210.4 |
Cash paid for interest | $ 80.2 | $ 78.7 | $ 86.2 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||||||
Feb. 09, 2023 | Feb. 08, 2023 | Feb. 09, 2022 | Feb. 08, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | May 05, 2022 | Feb. 28, 2019 | |
Subsequent Event [Line Items] | ||||||||
Repurchase of common stock (in shares) | 2,700,000 | 113,000 | ||||||
Repurchase of common stock under share repurchase authorization | $ 332,800 | $ 14,700 | ||||||
Common stock, shares authorized | 800,000,000 | 800,000,000 | 1,000,000,000 | 500,000,000 | ||||
Remaining authorization for future share repurchases | $ 823,900 | |||||||
Percent increase in cash dividend | 10% | |||||||
Dividends paid per share (in dollars per share) | $ 0.22 | $ 0.20 | ||||||
Treasury stock (in shares) | 38,537,635 | 36,137,864 | ||||||
Treasury stock, cost | $ 1,902,964 | $ 1,573,000 | ||||||
Number of shares outstanding | 230,100,000 | 231,700,000 | ||||||
Subsequent Event | ||||||||
Subsequent Event [Line Items] | ||||||||
Percent increase in cash dividend | 14% | |||||||
Dividends paid per share (in dollars per share) | $ 0.25 | $ 0.22 |